<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1475" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1475/" /><meta name="ncbi_pagename" content="Aicardi-Goutières Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Aicardi-Goutières Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Aicardi-Goutières Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/11/22" /><meta name="citation_author" content="Yanick J Crow" /><meta name="citation_pmid" content="20301648" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1475/" /><meta name="citation_keywords" content="Deoxynucleoside triphosphate triphosphohydrolase SAMHD1" /><meta name="citation_keywords" content="Double-stranded RNA-specific adenosine deaminase" /><meta name="citation_keywords" content="Interferon-induced helicase C domain-containing protein 1" /><meta name="citation_keywords" content="Ribonuclease H2 subunit A" /><meta name="citation_keywords" content="Ribonuclease H2 subunit B" /><meta name="citation_keywords" content="Ribonuclease H2 subunit C" /><meta name="citation_keywords" content="Three prime repair exonuclease 1" /><meta name="citation_keywords" content="ADAR" /><meta name="citation_keywords" content="IFIH1" /><meta name="citation_keywords" content="RNASEH2A" /><meta name="citation_keywords" content="RNASEH2B" /><meta name="citation_keywords" content="RNASEH2C" /><meta name="citation_keywords" content="SAMHD1" /><meta name="citation_keywords" content="TREX1" /><meta name="citation_keywords" content="Aicardi-Goutieres Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Aicardi-Goutières Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Yanick J Crow" /><meta name="DC.Date" content="2016/11/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1475/" /><meta name="description" content="Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known." /><meta name="og:title" content="Aicardi-Goutières Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1475/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ags/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1475/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE891FD3E03F4B8100000000099603CA.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1475_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1475_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/aic/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/alagille/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1475_"><span class="title" itemprop="name">Aicardi-Gouti&#x000e8;res Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Yanick J Crow</span>, MBBS, BMedSci, MRCP, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1475_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1475_ai__"><div class="contrib half_rhythm"><span itemprop="author">Yanick J Crow</span>, MBBS, BMedSci, MRCP, PhD<div class="affiliation small">Laboratory of Neurogenetics and Neuroinflammation<br />Institut Imagine<br />Paris, France</div><div class="affiliation small">Manchester Centre for Genomic Medicine<br />University of Manchester<br />Manchester, United Kingdom</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 29, 2005</span>; Last Update: <span itemprop="dateModified">November 22, 2016</span>.</p><p><em>Estimated reading time: 31 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ags.Summary" itemprop="description"><h2 id="_ags_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Most characteristically, Aicardi-Gouti&#x000e8;res syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> infection. Otherwise, most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with pathogenic variants in the AGS-related genes is not yet known.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of AGS is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>:</p><ul><li class="half_rhythm"><div>With typical clinical findings and characteristic abnormalities on cranial CT (calcification of the basal ganglia and white matter) and MRI (leukodystrophic changes);</div><div>and/or</div></li><li class="half_rhythm"><div>By the identification of one of the following:</div><ul><li class="half_rhythm"><div>Biallelic pathogenic variants in <i>ADAR</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, or <i>TREX1</i></div></li><li class="half_rhythm"><div>Specific <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pathogenic variants in <i>TREX1</i> and <i>ADAR</i></div></li><li class="half_rhythm"><div>A variety of <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pathogenic variants in <i>IFIH1</i></div></li></ul></li></ul></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Chest physiotherapy and treatment of respiratory complications; attention to diet and feeding methods to assure adequate caloric intake and avoid aspiration; management of seizures using standard protocols.</p><p><i>Surveillance:</i> Monitoring for signs of diabetes insipidus in the neonatal period; repeat ophthalmologic examinations at least for the first few years of life to evaluate for evidence of glaucoma; monitoring for evidence of scoliosis, insulin-dependent diabetes mellitus (IDDM), and hypothyroidism.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>AGS is most frequently inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner; in a few instances the disease can result from specific <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> or inherited <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pathogenic variants in <i>ADAR</i> or <i>TREX1</i>, and a variety of <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> autosomal dominant pathogenic variants in <i>IFIH1</i>. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with autosomal recessive AGS has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Individuals with AGS do not typically reproduce. Once the pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, prenatal testing for a pregnancy at increased risk for AGS, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible options.</p></div></div><div id="ags.Diagnosis"><h2 id="_ags_Diagnosis_">Diagnosis</h2><p>In its most characteristic form, Aicardi-Gouti&#x000e8;res syndrome (AGS) can be considered an early-onset encephalopathy associated with significant intellectual and physical disability.</p><div id="ags.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Aicardi-Gouti&#x000e8;res syndrome (AGS) <b>should be suspected</b> in individuals with the following clinical, neuroimaging, and supportive laboratory findings [<a class="bk_pop" href="#ags.REF.gouti_res.1998.900">Gouti&#x000e8;res et al 1998</a>, <a class="bk_pop" href="#ags.REF.lanzi.2002.a9">Lanzi et al 2002</a>, <a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>, <a class="bk_pop" href="#ags.REF.livingston.2013.46">Livingston et al 2013</a>].</p><div id="ags.Clinical_features"><h4>Clinical features</h4><ul><li class="half_rhythm"><div>Encephalopathy and/or significant intellectual disability</div></li><li class="half_rhythm"><div>Acquired microcephaly during the first year of life</div></li><li class="half_rhythm"><div>Dystonia and spasticity</div></li><li class="half_rhythm"><div>Sterile pyrexias</div></li><li class="half_rhythm"><div>Hepatosplenomegaly</div></li><li class="half_rhythm"><div>Chilblain lesions on the feet, hands, ears, and sometimes more generalized mottling of the skin. See <a class="figpopup" href="/books/NBK1475/figure/ags.F1/?report=objectonly" target="object" rid-figpopup="figagsF1" rid-ob="figobagsF1">Figure 1</a>.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figagsF1" co-legend-rid="figlgndagsF1"><a href="/books/NBK1475/figure/ags.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figagsF1" rid-ob="figobagsF1"><img class="small-thumb" src="/books/NBK1475/bin/ags-Image001.gif" src-large="/books/NBK1475/bin/ags-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndagsF1"><h4 id="ags.F1"><a href="/books/NBK1475/figure/ags.F1/?report=objectonly" target="object" rid-ob="figobagsF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Examples of chilblains seen in AGS Rice et al [2007b]; reprinted with permission of <i>The American Journal of Human Genetics</i>, University of Chicago Press.</p></div></div><p>Exclusion criteria include the following:</p><ul><li class="half_rhythm"><div>Evidence of prenatal/perinatal infection including, but not limited to, CMV, toxoplasmosis, rubella, herpes simplex, Zika, and HIV</div></li><li class="half_rhythm"><div>Evidence of a known other metabolic disorder or neurodegenerative disorder</div></li></ul></div><div id="ags.Neuroimaging"><h4>Neuroimaging</h4><ul><li class="half_rhythm"><div class="half_rhythm">Calcification (best visualized on CT scan) of the basal ganglia, particularly the putamen, globus pallidus and thalamus but also extending into the white matter, sometimes in a para- (rather than true peri-) ventricular distribution [<a class="bk_pop" href="#ags.REF.lanzi.2002.a9">Lanzi et al 2002</a>, <a class="bk_pop" href="#ags.REF.uggetti.2009.1971">Uggetti et al 2009</a>, <a class="bk_pop" href="#ags.REF.livingston.2013.46">Livingston et al 2013</a>]. See <a class="figpopup" href="/books/NBK1475/figure/ags.F2/?report=objectonly" target="object" rid-figpopup="figagsF2" rid-ob="figobagsF2">Figure 2</a>.</div><div class="half_rhythm">Note: Intracranial calcification is not always recognized on MRI, the initial imaging modality employed in most units.</div></li><li class="half_rhythm"><div class="half_rhythm">White matter changes, particularly affecting the frontotemporal regions with (in severe cases) temporal lobe cyst-like formation. See <a class="figpopup" href="/books/NBK1475/figure/ags.F3/?report=objectonly" target="object" rid-figpopup="figagsF3" rid-ob="figobagsF3">Figure 3</a>.</div><ul><li class="half_rhythm"><div>On MRI, appears on T<sub>2</sub>-weighted images as a hyperintense signal most commonly located around the horns of the ventricles (<a class="figpopup" href="/books/NBK1475/figure/ags.F3/?report=objectonly" target="object" rid-figpopup="figagsF3" rid-ob="figobagsF3">Figure 3B</a>)</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Cerebral atrophy, which may be progressive and involve the periventricular white matter and sulci</div><ul><li class="half_rhythm"><div>Cerebellar atrophy and brain stem atrophy may also be prominent (<a class="figpopup" href="/books/NBK1475/figure/ags.F3/?report=objectonly" target="object" rid-figpopup="figagsF3" rid-ob="figobagsF3">Figure 3D</a>) [<a class="bk_pop" href="#ags.REF.crow.2004a.303">Crow et al 2004a</a>, <a class="bk_pop" href="#ags.REF.sanchis.2005.701">Sanchis et al 2005</a>].</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Bilateral striatal necrosis</div></li><li class="half_rhythm"><div class="half_rhythm">Intracerebral vasculopathy including intracranial stenosis, moyamoya, and aneurysms</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figagsF2" co-legend-rid="figlgndagsF2"><a href="/books/NBK1475/figure/ags.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figagsF2" rid-ob="figobagsF2"><img class="small-thumb" src="/books/NBK1475/bin/ags-Image002.gif" src-large="/books/NBK1475/bin/ags-Image002.jpg" alt="Figure 2. . Examples of intracranial calcification on CT scan in individuals with AGS." /></a><div class="icnblk_cntnt" id="figlgndagsF2"><h4 id="ags.F2"><a href="/books/NBK1475/figure/ags.F2/?report=objectonly" target="object" rid-ob="figobagsF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Examples of intracranial calcification on CT scan in individuals with AGS. Calcification is seen: A. In the basal ganglia;</p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figagsF3" co-legend-rid="figlgndagsF3"><a href="/books/NBK1475/figure/ags.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figagsF3" rid-ob="figobagsF3"><img class="small-thumb" src="/books/NBK1475/bin/ags-Image003.gif" src-large="/books/NBK1475/bin/ags-Image003.jpg" alt="Figure 3. " /></a><div class="icnblk_cntnt" id="figlgndagsF3"><h4 id="ags.F3"><a href="/books/NBK1475/figure/ags.F3/?report=objectonly" target="object" rid-ob="figobagsF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">The spectrum of brain changes seen on MRI in AGS A. Hypointensity on T<sub>1</sub>-weighted imaging of the white matter</p></div></div></div><div id="ags.Supportive_Laboratory_Findings"><h4>Supportive Laboratory Findings</h4><p><b>Peripheral blood</b></p><ul><li class="half_rhythm"><div>Positive interferon signature identified using <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a> analysis of RNA/<a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> [<a class="bk_pop" href="#ags.REF.rice.2013a.1159">Rice et al 2013a</a>, <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>]</div></li><li class="half_rhythm"><div>Elevated liver enzymes</div></li><li class="half_rhythm"><div>Thrombocytopenia</div></li></ul><p><b>Cerebrospinal fluid (CSF)</b></p><ul><li class="half_rhythm"><div>Chronic CSF leukocytosis, defined as more than five lymphocytes/mm<sup>3</sup> CSF.</div><ul><li class="half_rhythm"><div>Typical values range from five to 100 lymphocytes/mm<sup>3</sup> [<a class="bk_pop" href="#ags.REF.gouti_res.1998.900">Gouti&#x000e8;res et al 1998</a>, <a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>, <a class="bk_pop" href="#ags.REF.rice.2013a.1159">Rice et al 2013a</a>].</div></li><li class="half_rhythm"><div>A decrease in the number of lymphocytes occurs with time, although high cell counts may persist for several years.</div></li><li class="half_rhythm"><div>A normal cell count can be observed in the presence of elevated concentrations of IFN-&#x003b1; in the CSF even at an early stage of the disease [<a class="bk_pop" href="#ags.REF.crow.2003.183">Crow et al 2003</a>, <a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>].</div></li></ul></li><li class="half_rhythm"><div>Increased interferon-alpha (IFN-&#x003b1;) activity in the CSF (normal: &#x0003c;2 IU/mL)</div><ul><li class="half_rhythm"><div>Recorded IFN-&#x003b1; activity is usually highest in the early stages of the disease. The IFN-&#x003b1; CSF activity can normalize over the first three to four years of life [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>, <a class="bk_pop" href="#ags.REF.rice.2013a.1159">Rice et al 2013a</a>].</div></li><li class="half_rhythm"><div>Recorded IFN-&#x003b1; activity is usually higher in CSF than in blood, where it may be normal.</div></li><li class="half_rhythm"><div>High IFN-&#x003b1; activity has been identified in fetal blood at 26 weeks' gestation [<a class="bk_pop" href="#ags.REF.desanges.2006.153">Desanges et al 2006</a>].</div></li></ul></li><li class="half_rhythm"><div>Increased concentration of neopterin in the CSF [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>]</div><ul><li class="half_rhythm"><div>Levels are highest in the early stages of the disease and can normalize over time.</div></li><li class="half_rhythm"><div>Levels of the neurotransmitter metabolites 5HIAA, HVA, and 5MTHF are normal.</div></li></ul></li></ul></div></div><div id="ags.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of AGS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and characteristic abnormalities on cranial CT (calcification of the basal ganglia and white matter) and MRI (leukodystrophic changes) and/or by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ADAR</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, or <i>TREX1</i>; specific <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pathogenic variants in <i>TREX1</i> and <i>ADAR</i>; or a variety of heterozygous autosomal dominant pathogenic variants in <i>IFIH1.</i></p><p>Molecular testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> can be pursued based on the individual's ethnicity and/or in the order in which pathogenic variants most commonly occur (see <a class="figpopup" href="/books/NBK1475/table/ags.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figagsTmoleculargenetictestingusedin" rid-ob="figobagsTmoleculargenetictestingusedin">Table 1</a>)<i>.</i></p><ul><li class="half_rhythm"><div>If only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified in <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, or <i>SAMHD1</i>, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> can be considered next.</div></li><li class="half_rhythm"><div>Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> may also be considered if a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that is not known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> AGS is identified in <i>TREX1</i> or <i>ADAR</i>.</div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ADAR</i>, <i>IFIH1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>TREX1</i>, and other genes of interest (see <a href="#ags.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included and the <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of multigene panels vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>ADAR</i>, <i>IFIH1, RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C, SAMHD1,</i> and <i>TREX1</i>) fails to confirm a diagnosis in an individual with features of AGS. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="ags.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Aicardi-Gouti&#x000e8;res Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of AGS Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Test Method</th></tr><tr><th headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></th><th headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADAR</i></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7%</td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">32/32 alleles&#x000a0;<sup>6</sup></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IFIH1</i></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3%</td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/17 alleles&#x000a0;<sup>8</sup></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RNASEH2A</i></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%</td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">34/34 alleles&#x000a0;<sup>9</sup></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RNASEH2B</i></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">36%</td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%&#x000a0;<sup>10</sup></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RNASEH2C</i></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12%</td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%&#x000a0;<sup>12,&#x000a0;13</sup></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SAMHD1</i></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13%</td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Up to 95%&#x000a0;<sup>14</sup></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Up to 30%&#x000a0;<sup>14,&#x000a0;15</sup></td></tr><tr><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TREX1</i></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23%</td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%&#x000a0;<sup>16</sup></td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%</td><td headers="hd_h_ags.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_ags.T.molecular_genetic_testing_used_in_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ags.TF.1.1"><p class="no_margin">See <a href="/books/NBK1475/#ags.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ags.TF.1.2"><p class="no_margin">See <a href="#ags.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="ags.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="ags.TF.1.4"><p class="no_margin">Sequence analysis of the coding regions and splice sites of <i>ADAR</i>, <i>IFIH1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, and <i>TREX1</i> has identified pathogenic variants in approximately 90%-95% of individuals with clinical and MRI presentation of AGS [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>, <a class="bk_pop" href="#ags.REF.rice.2009.829">Rice et al 2009</a>, <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>].</p></div></dd><dt>5. </dt><dd><div id="ags.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="ags.TF.1.6"><p class="no_margin">32/32 alleles were detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> [<a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>]. A dominant <a class="figpopup" href="/books/NBK1475/table/ags.T.selected_adar_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figagsTselectedadarpathogenicvariants" rid-ob="figobagsTselectedadarpathogenicvariants">p.Gly1007Arg</a> variant in <i>ADAR</i> has been reported [<a class="bk_pop" href="#ags.REF.rice.2012.1243">Rice et al 2012</a>, <a class="bk_pop" href="#ags.REF.livingston.2014a.76">Livingston et al 2014a</a>]. A recurrent <i>ADAR</i> variant, <a class="figpopup" href="/books/NBK1475/table/ags.T.selected_adar_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figagsTselectedadarpathogenicvariants" rid-ob="figobagsTselectedadarpathogenicvariants">p.Pro193Ala</a>, is seen in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons of European origin.</p></div></dd><dt>7. </dt><dd><div id="ags.TF.1.7"><p class="no_margin">No deletions or duplications involving <i>ADAR, IFIH1, RNASEH2A</i>, <i>RNASEH2C</i>, or <i>TREX1</i> have been reported to cause Aicardi-Gouti&#x000e8;res syndrome.</p></div></dd><dt>8. </dt><dd><div id="ags.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#ags.REF.rice.2014.503">Rice et al [2014]</a>, <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al [2015]</a></p></div></dd><dt>9. </dt><dd><div id="ags.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al [2007b]</a>, <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al [2015]</a></p></div></dd><dt>10. </dt><dd><div id="ags.TF.1.10"><p class="no_margin">90% of individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RNASEH2B</i> are either <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for the <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> change (<a class="figpopup" href="/books/NBK1475/table/ags.T.selected_rnaseh2b_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figagsTselectedrnaseh2bpathogenicvaria" rid-ob="figobagsTselectedrnaseh2bpathogenicvaria">p.Ala177Thr</a>).</p></div></dd><dt>11. </dt><dd><div id="ags.TF.1.11"><p class="no_margin">A <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>RNASEH2B</i> exons two through five has been reported [<a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>].</p></div></dd><dt>12. </dt><dd><div id="ags.TF.1.12"><p class="no_margin"><a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al [2007b]</a>, <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al [2015]</a></p></div></dd><dt>13. </dt><dd><div id="ags.TF.1.13"><p class="no_margin">The <i>RNASEH2C</i> variant <a class="figpopup" href="/books/NBK1475/table/ags.T.selected_rnaseh2c_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figagsTselectedrnaseh2cpathogenicvaria" rid-ob="figobagsTselectedrnaseh2cpathogenicvaria">p.Arg69Trp</a> is seen particularly frequently in Asian (most commonly Pakistani) families and represents an ancient <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>].</p></div></dd><dt>14. </dt><dd><div id="ags.TF.1.14"><p class="no_margin">25/26 alleles [<a class="bk_pop" href="#ags.REF.rice.2009.829">Rice et al 2009</a>] and 47/67 alleles [<a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>] were detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. Note: <a class="bk_pop" href="#ags.REF.rice.2009.829">Rice et al [2009]</a> did not perform <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> and in some families in the study no pathogenic variants were detected.</p></div></dd><dt>15. </dt><dd><div id="ags.TF.1.15"><p class="no_margin">A <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> including <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 has been observed in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> ancestry and very likely represents a <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> [<a class="bk_pop" href="#ags.REF.ramesh.2010.725">Ramesh et al 2010</a>]. 20/67 alleles in <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al [2015]</a> were detectable by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>; however, this study included persons of Ashkenazi Jewish descent. Note: A <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> deletion of &#x02265;1 exons can be suspected by the failure of exons to amplify by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a>. A recurrent splice acceptor site <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK1475/table/ags.T.selected_samhd1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figagsTselectedsamhd1pathogenicvariant" rid-ob="figobagsTselectedsamhd1pathogenicvariant">c.1411-2A&#x0003e;G</a>) in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 12 is seen in persons of Amish ancestry and represents an ancient founder variant [<a class="bk_pop" href="#ags.REF.xin.2011.5372">Xin et al 2011</a>].</p></div></dd><dt>16. </dt><dd><div id="ags.TF.1.16"><p class="no_margin">In approximately 100 individuals with <i>TREX1</i>-related AGS, all pathogenic variants were detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>, <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>]. A recurrent <a class="figpopup" href="/books/NBK1475/table/ags.T.selected_trex1_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figagsTselectedtrex1pathogenicvariants" rid-ob="figobagsTselectedtrex1pathogenicvariants">p.Arg164Ter</a> <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> in <i>TREX1</i> is seen in individuals of Cree ancestry. The most prevalent <i>TREX1</i> variant in AGS is a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> change (<a class="figpopup" href="/books/NBK1475/table/ags.T.selected_trex1_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figagsTselectedtrex1pathogenicvariants" rid-ob="figobagsTselectedtrex1pathogenicvariants">p.Arg114His</a>) that is particularly common in people from northern Europe.</p></div></dd></dl></div></div></div></div></div><div id="ags.Clinical_Characteristics"><h2 id="_ags_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ags.Clinical_Description"><h3>Clinical Description</h3><p>In its most characteristic form, Aicardi-Gouti&#x000e8;res syndrome (AGS) can be considered an early-onset encephalopathy associated with significant intellectual and physical disability.</p><p><b>Pregnancy, delivery, and the neonatal period</b> are normal in approximately 80% of infants with Aicardi-Gouti&#x000e8;res syndrome (AGS) [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>]. However, brain calcifications can be identified in utero [<a class="bk_pop" href="#ags.REF.le_garrec.2005.28">Le Garrec et al 2005</a>] and 20% of cases, mainly those caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>TREX1</i>, present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture reminiscent of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> infection.</p><p>All other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. The majority of these later-presenting infants exhibit subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. The encephalopathic phase usually lasts several months. The opinion of most pediatricians caring for such children is that the disease does not progress beyond the encephalopathic period; occasionally, however, affected individuals do appear to show progression and/or episodes of regression. Death is usually considered to be secondary to the neurologic damage incurred during the initial disease episode, not to further regression. Several affected individuals older than age 30 years show no obvious signs of disease progression.</p><p><b>Neurologic features.</b> Typically, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have peripheral spasticity, dystonic posturing (particularly of the upper limbs), truncal hypotonia, and poor head control. Seizures are reported in up to half of affected children, but are usually relatively easily controlled [<a class="bk_pop" href="#ags.REF.gouti_res.1998.900">Gouti&#x000e8;res et al 1998</a>, <a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>]. A number of children demonstrate a marked startle reaction to sudden noise, and the differentiation from epilepsy can be difficult. Most affected individuals have severe intellectual and physical impairment. Variability in the severity of the neurologic outcome can be observed among sibs. Most affected children exhibit a severe acquired microcephaly; in children with preserved intellect head circumference can be normal.</p><p><b>Hearing</b> is almost always normal.</p><p><b>Ophthalmology.</b> Visual function varies from normal to cortical blindness. Ocular structures are almost invariably normal on examination. However, there is a risk of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> glaucoma or later-onset glaucoma [<a class="bk_pop" href="#ags.REF.crow.2004a.303">Crow et al 2004a</a>, <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>].</p><p><b>Skin lesions.</b> As many as 40% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>] have skin lesions with chilblains on the fingers and toes and sometimes the ears and other pressure points (e.g., elbows) [<a class="bk_pop" href="#ags.REF.tolmie.1995.881">Tolmie et al 1995</a>, <a class="bk_pop" href="#ags.REF.stephenson.2002">Stephenson 2002</a>] (see <a class="figpopup" href="/books/NBK1475/figure/ags.F1/?report=objectonly" target="object" rid-figpopup="figagsF1" rid-ob="figobagsF1">Figure 1</a>). The cutaneous lesions may be complicated by periungual infection and necrosis.</p><p><b>Other</b></p><ul><li class="half_rhythm"><div><b>Intracranial large-vessel disease.</b> An additional previously undescribed feature of AGS, which so far appears to be almost exclusively related to <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SAMHD1</i>, is intracranial large-vessel disease causing both intracranial stenoses (in some cases reminiscent of moyamoya syndrome) and aneurysms (see <a href="#ags.Phenotype_Correlations_by_Gene">Phenotype Correlations by Gene</a>) [<a class="bk_pop" href="#ags.REF.ramesh.2010.725">Ramesh et al 2010</a>, <a class="bk_pop" href="#ags.REF.thiele.2010.e1836">Thiele et al 2010</a>, <a class="bk_pop" href="#ags.REF.du_moulin.2011.e232">du Moulin et al 2011</a>, <a class="bk_pop" href="#ags.REF.xin.2011.5372">Xin et al 2011</a>].</div></li><li class="half_rhythm"><div><b>Refractory four-limb dystonia.</b> Several individuals with <i>ADAR</i> pathogenic variants have been reported to demonstrate an acute or subacute onset of refractory four-limb dystonia starting between age eight months and five years [<a class="bk_pop" href="#ags.REF.livingston.2014a.76">Livingston et al 2014a</a>, <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>] (see <a href="#ags.Phenotype_Correlations_by_Gene">Phenotype Correlations by Gene</a>).</div><ul><li class="half_rhythm"><div>Individuals can be developmentally normal at initial presentation.</div></li><li class="half_rhythm"><div>This <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> can occur due to either <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ADAR</i> or the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Gly1007Arg in <i>ADAR</i>.</div></li><li class="half_rhythm"><div>Like other AGS-related phenotypes, bilateral striatal necrosis due to <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ADAR</i> or the recurrent dominant pathogenic p.Gly1007Arg variant in <i>ADAR1</i> are typically associated with an upregulation of ISGs.</div></li></ul></li></ul><p>Additional infrequently observed features of AGS are summarized in <a class="figpopup" href="/books/NBK1475/table/ags.T.infrequent_features_seen_in_a_coho/?report=objectonly" target="object" rid-figpopup="figagsTinfrequentfeaturesseeninacoho" rid-ob="figobagsTinfrequentfeaturesseeninacoho">Table 2</a>.</p><div id="ags.T.infrequent_features_seen_in_a_coho" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Infrequent Features Seen in a Cohort of 123 Individuals with Molecularly Confirmed AGS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.T.infrequent_features_seen_in_a_coho/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.T.infrequent_features_seen_in_a_coho_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" style="text-align:left;vertical-align:middle;">Feature</th><th id="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2" colspan="4" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Number of Affected Individuals by Gene</th></tr><tr><th headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2" id="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><i>RNASEH2A</i></th><th headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2" id="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RNASEH2B</i></th><th headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2" id="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RNASEH2C</i></th><th headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2" id="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TREX1</i></th></tr></thead><tbody><tr><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Scoliosis</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiomegaly</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td></tr><tr><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abnormal antibody profile</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Preserved language</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Demyelinating peripheral neuropathy</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital glaucoma</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Micropenis</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypothyroidism</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Insulin-dependent diabetes mellitus</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Transitory deficiency of antidiuretic hormone</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_1_2 hd_h_ags.T.infrequent_features_seen_in_a_coho_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al [2007b]</a>. Note: This paper was published before it was determined that pathogenic variants in <i>ADAR, IFIH1,</i> and <i>SAMHD1</i> can cause AGS.</p></div></dd></dl></div></div></div><p><b>Neuroimaging/neuropathologic findings</b></p><ul><li class="half_rhythm"><div>Calcifications on neuroimaging:</div><ul><li class="half_rhythm"><div>Are often punctate but may be dense and rock-like;</div></li><li class="half_rhythm"><div>When identified at diagnosis tend to remain stable, although progression can be observed [<a class="bk_pop" href="#ags.REF.lanzi.2002.a9">Lanzi et al 2002</a>, <a class="bk_pop" href="#ags.REF.lanzi.2005.1621">Lanzi et al 2005</a>];</div></li><li class="half_rhythm"><div>Are not correlated with the severity of neurologic outcome; in rare cases, calcifications may be absent and may or may not be seen on repeat scans. Therefore, their absence does not rule out the diagnosis [<a class="bk_pop" href="#ags.REF.aicardi.1984.49">Aicardi &#x00026; Gouti&#x000e8;res 1984</a>].</div></li></ul></li><li class="half_rhythm"><div>The main neuropathologic findings identified in severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals include [<a class="bk_pop" href="#ags.REF.kumar.1998.508">Kumar et al 1998</a>, <a class="bk_pop" href="#ags.REF.barth.2002">Barth 2002</a>]:</div><ul><li class="half_rhythm"><div>Diffuse but non-homogeneous demyelination with astrocytosis; absence of signs of storage or myelin breakdown;</div></li><li class="half_rhythm"><div>Multiple wedge-shaped microinfarcts in the neocortex and cerebellar cortex, suggestive of a microangiopathy;</div></li><li class="half_rhythm"><div>Calcific deposits in the white matter, thalami, basal ganglia, and dentate nuclei;</div></li><li class="half_rhythm"><div>Calcification in the media, adventitia, and perivascular spaces of small vessels;</div></li><li class="half_rhythm"><div>Inflammation in the leptomeninges and areas of necrosis.</div></li></ul></li></ul></div><div id="ags.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p>In general, the early-onset neonatal form of AGS is most frequently seen in association with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RNASEH2A</i>, <i>RNASEH2C</i>, <i>or TREX1</i>. The later-onset presentation (sometimes occurring after several months of normal development and occasionally associated with remarkably preserved neurologic function) is most frequently seen in association with biallelic pathogenic variants in <i>RNASEH2B</i>, <i>SAMHD1</i>, or <i>ADAR</i> but may also be seen in individuals who have an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ADAR</i> or <i>IFIH1</i> [<a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>].</p><p>Mortality is correlated with <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>: 34% of individuals with <i>RNASEH2A</i>, <i>RNASEH2C</i>, and <i>TREX1</i> pathogenic variants were known to have died compared to 8% with <i>RNASEH2B</i> pathogenic variants (p=0.001) [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>]. The mortality associated with other genotypes is less clear.</p><p><b><i>ADAR.</i></b> Pathogenic variants in <i>ADAR</i> have been associated with a clinical presentation of acute bilateral striatal necrosis.</p><p>A subgroup of individuals with <i>ADAR</i> pathogenic variants can present with symmetric signal changes in the caudate and putamen, often associated with swelling and later shrinkage in the context of an acute or subacute onset of refractory four-limb dystonia. Cases have been identified with onset as late as age four years on a background of completely normal development [<a class="bk_pop" href="#ags.REF.livingston.2014a.76">Livingston et al 2014a</a>, <a class="bk_pop" href="#ags.REF.la_piana.2014.815">La Piana et al 2014</a>].</p><p><i>ADAR</i>-related disease should be considered in the differential diagnosis of apparently nonsyndromic bilateral striatal necrosis (BSN) with severe dystonia of varying evolution. The finding of an interferon signature provides a useful screening test for the presence of <i>ADAR</i> pathogenic variants in this context.</p><p><b><i>RNASEH2B</i>.</b> Some individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RNASEH2B</i> have relatively preserved intellectual function, with a few having a completely normal IQ and head circumference [<a class="bk_pop" href="#ags.REF.mcentagart.1998.163">McEntagart et al 1998</a>].</p><p><b><i>RNASEH2C</i>.</b> A family with a recurrent Asian <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> in <i>RNASEH2C</i> and striking <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> has been described [<a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>].</p><p><b><i>SAMHD1</i></b></p><ul><li class="half_rhythm"><div>Intracerebral vasculopathy, including intracranial stenosis and aneurysms, is observed more frequently in individuals who have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SAMHD1</i>.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#ags.REF.dale.2010.938">Dale et al [2010]</a> reported two sibs who had <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants in <i>SAMHD1</i>. The older girl showed mild intellectual disability with microcephaly. Her younger brother had significant spastic paraparesis with normal intellect and head size. Both children had an unclassified chronic inflammatory skin condition with chilblains and recurrent mouth ulcers. One of the sibs had a chronic progressive deforming arthropathy of the small and large joints with secondary contractures. Similar joint involvement was described by <a class="bk_pop" href="#ags.REF.ramantani.2010.1469">Ramantani et al [2010]</a> (see also <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al [2015]</a>).</div></li><li class="half_rhythm"><div>Biallelic pathogenic variants in <i>SAMHD1</i> are most frequently associated with chilblains and glaucoma [<a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>].</div></li></ul></div><div id="ags.Nomenclature"><h3>Nomenclature</h3><p>The microcephaly-intracranial calcification syndrome (MICS; also known as pseudo-TORCH syndrome or Baraitser-Reardon syndrome) was previously differentiated from AGS on the basis of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> microcephaly and the presence of non-neurologic abnormalities including elevation of liver enzymes, hepatomegaly, and thrombocytopenia at birth [<a class="bk_pop" href="#ags.REF.reardon.1994.58">Reardon et al 1994</a>]. However, recent studies have shown that these same features can be seen in persons with AGS in whom pathogenic variants in one of the associated genes have been identified [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>]. Of note, in the majority of MICS cases reported no information is available on CSF cell count and IFN-&#x003b1; concentration; thus it is probable that most cases of MICS are in fact AGS.</p><p><b>"Familial systemic lupus erythematosus."</b>
<a class="bk_pop" href="#ags.REF.dale.2000.155">Dale et al [2000]</a> described two children of <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> parents with early-onset encephalopathy, intracranial calcifications, chilblain skin lesions, and the progressive production of high levels of autoantibodies. CSF was not analyzed. These cases most likely represent AGS [<a class="bk_pop" href="#ags.REF.aicardi.2000.113">Aicardi &#x00026; Gouti&#x000e8;res 2000</a>]. Additional individuals with AGS who have signs and symptoms similar to systemic lupus erythematosus have also been described.</p></div><div id="ags.Prevalence"><h3>Prevalence</h3><p>The actual frequency of AGS is unknown.</p><p>Pathogenic variants have been found in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of all ethnic origins [<a class="bk_pop" href="#ags.REF.crow.2006a.917">Crow et al 2006a</a>, <a class="bk_pop" href="#ags.REF.crow.2006b.910">Crow et al 2006b</a>, <a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>, <a class="bk_pop" href="#ags.REF.rice.2013b.1066">Rice et al 2013b</a>] (see <a class="figpopup" href="/books/NBK1475/table/ags.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figagsTmoleculargenetictestingusedin" rid-ob="figobagsTmoleculargenetictestingusedin">Table 1</a>).</p></div></div><div id="ags.Genetically_Related_Allelic_Disorder"><h2 id="_ags_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>Other phenotypes caused by pathogenic variants in <i>ADAR</i>, <i>IFIH1</i>, <i>RNASEH2B</i>, and <i>TREX1</i> are listed in <a class="figpopup" href="/books/NBK1475/table/ags.T.allelic_disorders/?report=objectonly" target="object" rid-figpopup="figagsTallelicdisorders" rid-ob="figobagsTallelicdisorders">Table 3</a>.</p><div id="ags.T.allelic_disorders" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Allelic Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.T.allelic_disorders/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.T.allelic_disorders_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ags.T.allelic_disorders_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_ags.T.allelic_disorders_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADAR</i></th><th id="hd_h_ags.T.allelic_disorders_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IFIH1</i></th><th id="hd_h_ags.T.allelic_disorders_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RNASEH2B</i></th><th id="hd_h_ags.T.allelic_disorders_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SAMHD1</i></th><th id="hd_h_ags.T.allelic_disorders_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TREX1</i>&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_ags.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dyschromatosis symmetrica hereditaria 1 (DSH)&#x000a0;<sup>2</sup></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ags.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">"Pure" spastic paraparesis&#x000a0;<sup>3</sup> or childhood-onset paraparesis with normal intellect&#x000a0;<sup>4</sup></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ags.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Autosomal dominant retinal vasculopathy with cerebral leukodystrophy (RVCL)&#x000a0;<sup>5</sup></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_ags.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Systemic lupus erythematosus (SLE)&#x000a0;<sup>6</sup></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_ags.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree encephalitis&#x000a0;<sup>7</sup></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_ags.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial chilblain lupus (FLE)&#x000a0;<sup>8</sup></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_ags.T.allelic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ags.TF.3.1"><p class="no_margin">Mutation of <i>TREX1</i> can be associated with additional phenotypes not included in this table [<a class="bk_pop" href="#ags.REF.rice.2015.235">Rice et al 2015</a>].</p></div></dd><dt>2. </dt><dd><div id="ags.TF.3.2"><p class="no_margin">The <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>ADAR</i>
<a class="figpopup" href="/books/NBK1475/table/ags.T.selected_adar_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figagsTselectedadarpathogenicvariants" rid-ob="figobagsTselectedadarpathogenicvariants">p.Gly1007Arg</a> variant, which has been shown to cause <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> AGS [<a class="bk_pop" href="#ags.REF.rice.2012.1243">Rice et al 2012</a>], was previously described in two individuals with DSH demonstrating neurodegeneration with dystonia and intracranial calcification [<a class="bk_pop" href="#ags.REF.tojo.2006.1510">Tojo et al 2006</a>, <a class="bk_pop" href="#ags.REF.kondo.2008.662">Kondo et al 2008</a>].</p></div></dd><dt>3. </dt><dd><div id="ags.TF.3.3"><p class="no_margin"><a class="bk_pop" href="#ags.REF.crow.2014a.386">Crow et al [2014a]</a>, <a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al [2015]</a></p></div></dd><dt>4. </dt><dd><div id="ags.TF.3.4"><p class="no_margin"><a class="bk_pop" href="#ags.REF.rice.2014.503">Rice et al [2014]</a></p></div></dd><dt>5. </dt><dd><div id="ags.TF.3.5"><p class="no_margin"><a class="bk_pop" href="#ags.REF.richards.2007.1068">Richards et al [2007]</a> have shown that C terminus mutation of <i>TREX1</i> causes RVCL, an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> microvascular endotheliopathy variably associated with a retinal vasculopathy, migraine, Raynaud's phenomenon, stroke, and dementia with onset in middle age. This finding raises the possibility, unproven, that the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parents of children with AGS caused by <i>TREX1</i> pathogenic variants, at least those with variants in the C terminus of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, may be at risk of developing RVCL.</p></div></dd><dt>6. </dt><dd><div id="ags.TF.3.6"><p class="no_margin"><a class="bk_pop" href="#ags.REF.leekirsch.2007b.1065">Lee-Kirsch et al [2007b]</a> found <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>TREX1</i> in nine of 417 individuals with SLE. This finding raises the possibility that individuals with AGS caused by mutation of <i>TREX1</i> (as well as their heterozygous parents) may be at risk of developing signs and symptoms similar to SLE.</p></div></dd><dt>7. </dt><dd><div id="ags.TF.3.7"><p class="no_margin">Linkage analysis and measurement of CSF concentration of IFN-&#x003b1; suggested that AGS and Cree encephalitis were allelic [<a class="bk_pop" href="#ags.REF.crow.2003.183">Crow et al 2003</a>]; this was confirmed when <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> revealed that all children with Cree encephalitis are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="figpopup" href="/books/NBK1475/table/ags.T.selected_trex1_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figagsTselectedtrex1pathogenicvariants" rid-ob="figobagsTselectedtrex1pathogenicvariants">p.Arg164Ter</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TREX1</i>.</p></div></dd><dt>8. </dt><dd><div id="ags.TF.3.8"><p class="no_margin"><a class="bk_pop" href="#ags.REF.rice.2007a.811">Rice et al [2007a]</a> described a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TREX1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members of a family with chilblain lupus; a second distinct pathogenic variant was subsequently described by <a class="bk_pop" href="#ags.REF.leekirsch.2007a.531">Lee-Kirsch et al [2007a]</a>. Additional pathogenic variants have been described. FLE may also be caused by a heterozygous pathogenic variant in <i>SAMHD1</i> [<a class="bk_pop" href="#ags.REF.ravenscroft.2011.235">Ravenscroft et al 2011</a>].</p></div></dd></dl></div></div></div><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>RNASEH2A</i> or <i>RNASEH2C</i>.</p></div><div id="ags.Differential_Diagnosis"><h2 id="_ags_Differential_Diagnosis_">Differential Diagnosis</h2><p>Calcification of the basal ganglia is a nonspecific finding seen in many diseases. However, in the context of an early-onset encephalopathy, conditions to consider include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>TORCH <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> infections</b> are the most common conditions in the differential and the most important to rule out because misdiagnosis would result in erroneous counseling as to risk of recurrence.</div><div class="half_rhythm">Note: Other <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> infections, such as those associated with Zika and HIV, should also be considered in the differential diagnosis.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>The microcephaly-intracranial calcification syndrome (MICS).</b> Given the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of early-onset Aicardi-Gouti&#x000e8;res syndrome (AGS) cases (see <a href="#ags.Clinical_Characteristics">Clinical Characteristics</a>) [<a class="bk_pop" href="#ags.REF.reardon.1994.58">Reardon et al 1994</a>], it is likely that most cases of MICS are in fact AGS (see <a href="#ags.Nomenclature">Nomenclature</a>). However, a number of other phenotypes are associated with neonatal intracranial calcification [<a class="bk_pop" href="#ags.REF.knoblauch.2003.261">Knoblauch et al 2003</a>, <a class="bk_pop" href="#ags.REF.gardner.2005.362">Gardner et al 2005</a>]; thus, this phenotype undoubtedly represents a heterogeneous group of diseases (see <a href="#ags.Nomenclature">Nomenclature</a>).</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Band-like calcification polymicrogyria (BLC-PMG; pseudo-TORCH syndrome)</b> (OMIM <a href="http://omim.org/entry/251290" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">251290</a>) [<a class="bk_pop" href="#ags.REF.abdelsalam.2008.2929">Abdel-Salam et al 2008</a>, <a class="bk_pop" href="#ags.REF.briggs.2008.3173">Briggs et al 2008</a>] shows radiologic and clinical overlap with AGS, demonstrating intracranial calcification and significant psychomotor retardation with microcephaly and epilepsy. The condition can be differentiated by the observation of polymicrogyria (which has never been reported in AGS) and the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>OCLN</i> [<a class="bk_pop" href="#ags.REF.odriscoll.2010.354">O'Driscoll et al 2010</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Superficially, at least, the MRI scan findings in AGS with frontotemporal white matter changes and cysts can be confused with <a href="/books/n/gene/alexander/">Alexander disease,</a>
<a href="/books/n/gene/mlc/">megalencephalic leukoencephalopathy with subcortical cysts</a>, and <a href="/books/n/gene/cach/">childhood ataxia with central nervous system hypomyelination/vanishing white matter disease</a>. The degree of white matter hypomyelination at an early age has also prompted consideration of <a href="/books/n/gene/pmd/">Pelizeaus-Merzbacher disease</a> in some individuals. In general terms, AGS should be considered in the differential diagnosis of an unexplained leukoencephalopathy. This clinical point is of particular importance because intracranial calcification is not always recognized on MRI, the initial imaging modality employed in most medical facilities.</div></li><li class="half_rhythm"><div class="half_rhythm"><a href="/books/n/gene/cockayne/"><b>Classic Cockayne syndrome</b></a>
<b>(CS type 1),</b> a leukodystrophy with striocerebellar calcifications, is variably characterized by its distinctive facial features, dwarfism, nerve deafness, cataracts, retinal dystrophy, and skin photosensitivity. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Neonatal lupus erythematosus.</b>
<a class="bk_pop" href="#ags.REF.prendiville.2003.60">Prendiville et al [2003]</a> described basal ganglia calcifications and patchy white matter attenuation in infants with neonatal lupus erythematosus reminiscent of the imaging findings seen in AGS. These children demonstrated extensive erythematous skin lesions distinct from the chilblain lesions seen in AGS. The authors reported normal neurologic outcome in these cases.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hoyeraal Hreidarsson syndrome,</b> a severe form of <a href="/books/n/gene/dkc/">dyskeratosis congenita</a>, is caused by mutation in <i>DKC1</i> (<a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>) or <i>TINF2</i> (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>). Hoyeraal Hreidarsson syndrome presents in the first months of life with microcephaly, cerebellar hypoplasia, and intracerebral calcifications. Affected males develop a pancytopenia that persists (in contrast to the thrombocytopenia seen in some individuals with AGS, which usually resolves in the first few weeks of life).</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Mitochondrial cytopathies,</b> including <a href="/books/n/gene/narp/">Leigh syndrome</a> and the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> mitochondrial encephalopathy with intracerebral calcifications described by <a class="bk_pop" href="#ags.REF.samson.1994.510">Samson et al [1994]</a>. See also <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>3-hydroxyisobutyric aciduria</b> (OMIM <a href="http://omim.org/entry/236795" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">236795</a>). <a class="bk_pop" href="#ags.REF.chitayat.1992.86">Chitayat et al [1992]</a> described monozygotic male twins, born to non-<a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> parents, who had <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, microcephaly, migrational brain disorder, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> intracerebral calcification.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#ags.REF.blau.2003.642">Blau et al [2003]</a> described three individuals with microcephaly, severe intellectual disability and motor retardation, dyskinesia, spasticity, and occasional seizures with extremely high CSF concentrations of neopterin and biopterin and low CSF concentration of 5-methyltetrahydrofolate. Although reported as having AGS, they did not demonstrate a CSF lymphocytosis or elevation of IFN-&#x003b1; concentration. Thus, these individuals may have an undefined syndrome within the group of infants with encephalopathy and intracranial calcifications. However, it is now known that a similar pterin profile can be observed in individuals with molecularly confirmed AGS [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Cerebroretinal microangiopathy with calcifications and cysts</b>
<b>(CRMCC; Coats plus)</b> (OMIM <a href="http://omim.org/entry/612199" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">612199</a>) is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CTC1</i> [<a class="bk_pop" href="#ags.REF.crow.2004b.10">Crow et al 2004b</a>, <a class="bk_pop" href="#ags.REF.linnankivi.2006.1437">Linnankivi et al 2006</a>, <a class="bk_pop" href="#ags.REF.anderson.2012.338">Anderson et al 2012</a>, <a class="bk_pop" href="#ags.REF.livingston.2014b.175">Livingston et al 2014b</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Leukoencephalopathy, brain calcifications, and cysts (Labrune syndrome)</b> (OMIM <a href="http://omim.org/entry/614561" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614561</a>)</div></li></ul></div><div id="ags.Management"><h2 id="_ags_Management_">Management</h2><div id="ags.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Aicardi-Gouti&#x000e8;res syndrome (AGS), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Developmental assessment</div></li><li class="half_rhythm"><div>Assessment of feeding and nutritional status</div></li><li class="half_rhythm"><div>Ophthalmologic examination</div></li><li class="half_rhythm"><div>EEG to evaluate for seizures, if suspected</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="ags.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Chest physiotherapy and vigorous treatment of respiratory complications</div></li><li class="half_rhythm"><div>Attention to diet and method of feeding to assure adequate caloric intake</div></li><li class="half_rhythm"><div>Management of seizures using standard protocols</div></li></ul></div><div id="ags.Surveillance"><h3>Surveillance</h3><p>Surveillance includes the following:</p><ul><li class="half_rhythm"><div>Monitoring for signs of diabetes insipidus in the neonatal period</div></li><li class="half_rhythm"><div>Assessment for glaucoma at least for the first few years of life</div></li><li class="half_rhythm"><div>Monitoring of the spine for the development of scoliosis</div></li><li class="half_rhythm"><div>Monitoring for signs of insulin-dependent diabetes mellitus (IDDM) and hypothyroidism</div></li></ul></div><div id="ags.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#ags.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ags.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Research into the role of immunosuppressive agents in the treatment of AGS is ongoing [<a class="bk_pop" href="#ags.REF.crow.2009.r130">Crow &#x00026; Rehwinkel 2009</a>, <a class="bk_pop" href="#ags.REF.crow.2014.1">Crow et al 2014</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="ags.Other"><h3>Other</h3><p>Corticosteroids can lower the CSF concentration of interferon [PG Barth 2003, personal communication]; the clinical benefit of such treatment is unproven.</p><p>Note: The description of intracranial large-vessel disease in association with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SAMHD1</i> raises important questions about the management of such individuals. The occlusive and aneurysmal arteriopathies described could be amenable to treatment (revascularization for the former and coiling or clipping for the latter). Moreover, the likely inflammatory basis of the arteriopathy suggests that immunosuppression may play a role in management. A key question is whether inflammatory disease is active at the time of clinical presentation, or whether the arterial abnormalities observed represent the end result of a now-quiescent inflammatory process.</p><p>Given the lack of evidence, no definitive statement about these issues can be made at present. However, the potential for intervention exists, and it could be argued that some individuals (e.g., those with lesser psychomotor problems) warrant such intervention and should be actively screened for intracranial arteriopathy, if only by close inspection of the vasculature at the base of the brain seen on routine MRI. Chilblains were present in all the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals described by <a class="bk_pop" href="#ags.REF.ramesh.2010.725">Ramesh et al [2010]</a>, and it may be that their presence predicts an increased risk for intracranial vasculopathy.</p></div></div><div id="ags.Genetic_Counseling"><h2 id="_ags_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ags.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, and <i>SAMHD1</i>-related Aicardi-Gouti&#x000e8;res syndrome (AGS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><i>TREX1</i> and <i>ADAR</i>-related AGS can be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner depending on the specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><i>IFIH1</i>-related Aicardi-Gouti&#x000e8;res syndrome (AGS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="ags.Risk_to_Family_Members__Autosomal_Re"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one AGS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are not at risk of developing AGS; however, the findings of <a class="bk_pop" href="#ags.REF.leekirsch.2007b.1065">Lee-Kirsch et al [2007b]</a> and <a class="bk_pop" href="#ags.REF.richards.2007.1068">Richards et al [2007]</a> suggest that heterozygotes may be at increased risk of developing later-onset systemic lupus erythematosus (SLE) or retinal vasculopathy with cerebral leukodystrophy (RVCL), depending on the specific <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> involved (see <a href="#ags.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</a>).</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are not at risk of developing AGS; however, heterozygotes may be at increased risk of developing later-onset systemic lupus erythematosus (SLE) or retinal vasculopathy with cerebral leukodystrophy (RVCL), depending on the specific <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> involved (see <a href="#ags.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</a>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Most individuals with AGS do not reproduce.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an AGS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><div id="ags.Carrier_Heterozygote_Detection"><h4>Carrier (Heterozygote) Detection</h4><p>Carrier testing for at-risk relatives requires prior identification of the AGS-related pathogenic variants in the family.</p></div></div><div id="ags.Risk_to_Family_Members__Autosomal_Do"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">To date, most probands with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> AGS have had the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>TREX1</i>, <i>ADAR</i>, or <i>IFIH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>, <a class="bk_pop" href="#ags.REF.haaxma.2010.2612">Haaxma et al 2010</a>, <a class="bk_pop" href="#ags.REF.rice.2012.1243">Rice et al 2012</a>, <a class="bk_pop" href="#ags.REF.abe.2014.448">Abe et al 2014</a>].</div><div class="half_rhythm">Vertical transmission of pathogenic variants in <i>TREX1</i> (<a class="figpopup" href="/books/NBK1475/table/ags.T.selected_trex1_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figagsTselectedtrex1pathogenicvariants" rid-ob="figobagsTselectedtrex1pathogenicvariants">p.Asp18Asn</a>; <a class="bk_pop" href="#ags.REF.abe.2013.406">Abe et al [2013]</a>) and <i>ADAR</i> (<a class="figpopup" href="/books/NBK1475/table/ags.T.selected_adar_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figagsTselectedadarpathogenicvariants" rid-ob="figobagsTselectedadarpathogenicvariants">p.Gly1007Arg</a>; <a class="bk_pop" href="#ags.REF.rice.2012.1243">Rice et al [2012]</a>, <a class="bk_pop" href="#ags.REF.livingston.2014a.76">Livingston et al [2014a]</a>) has been reported.</div></li><li class="half_rhythm"><div class="half_rhythm">Molecular genetic testing is recommended for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div class="half_rhythm">If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, the proband most likely has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant. Another possible explanation is <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (though theoretically possible, no instances of germline mosaicism have been reported).</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>If the <i>TREX1</i>, <i>ADAR</i>, or <i>IFIH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> AGS has a 50% chance of inheriting the AGS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; however, most individuals with AGS do not reproduce.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="ags.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ags.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for AGS are possible.</p></div></div><div id="ags.Resources"><h2 id="_ags_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>International Aicardi-Gouti&#x000e8;res Syndrome Association (IAGSA)</b></div><div>Italy</div><div><b>Email:</b> associazione.iagsa@tiscali.it; iagsa@libero.it</div><div><a href="http://www.aicardi-goutieres.org/index.jsp" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aicardi-goutieres.org</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/aicardi-goutieres-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Aicardi-Goutieres syndrome</a></div></li><li class="half_rhythm"><div><b>United Leukodystrophy Foundation (ULF)</b></div><div>224 North Second Street</div><div>Suite 2</div><div>DeKalb IL 60115</div><div><b>Phone:</b> 800-728-5483 (toll-free); 815-748-3211</div><div><b>Fax:</b> 815-748-0844</div><div><b>Email:</b> office@ulf.org</div><div><a href="http://ulf.org/aicardi-goutieres-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Aicardi-Goutieres Syndrome</a></div></li><li class="half_rhythm"><div><b>Myelin Disorders Bioregistry Project</b></div><div><b>Email:</b> myelindisorders@cnmc.org</div><div><a href="https://www.chop.edu/research/myelin-disorders-biorepository-project" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myelin Disorders Bioregistry Project</a></div></li></ul></div><div id="ags.Molecular_Genetics"><h2 id="_ags_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ags.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Aicardi-Goutieres Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ags.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ags.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ags.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ags.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ags.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ags.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ags.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/103" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ADAR</i></a></td><td headers="hd_b_ags.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=103" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q21<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P55265" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Double-stranded RNA-specific adenosine deaminase</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ADAR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADAR database</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ADAR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADAR</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ADAR[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADAR</a></td></tr><tr><td headers="hd_b_ags.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/64135" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>IFIH1</i></a></td><td headers="hd_b_ags.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=64135" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q24<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9BYX4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Interferon-induced helicase C domain-containing protein 1</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/IFIH1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IFIH1 database</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=IFIH1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IFIH1</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=IFIH1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IFIH1</a></td></tr><tr><td headers="hd_b_ags.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10535" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RNASEH2A</i></a></td><td headers="hd_b_ags.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10535" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19p13<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75792" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ribonuclease H2 subunit A</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/RNASEH2A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RNASEH2A @ LOVD</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RNASEH2A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RNASEH2A</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RNASEH2A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RNASEH2A</a></td></tr><tr><td headers="hd_b_ags.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/79621" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RNASEH2B</i></a></td><td headers="hd_b_ags.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=79621" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">13q14<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q5TBB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ribonuclease H2 subunit B</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/RNASEH2B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RNASEH2B @ LOVD</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RNASEH2B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RNASEH2B</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RNASEH2B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RNASEH2B</a></td></tr><tr><td headers="hd_b_ags.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/84153" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RNASEH2C</i></a></td><td headers="hd_b_ags.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=84153" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q13<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8TDP1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ribonuclease H2 subunit C</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/RNASEH2C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RNASEH2C @ LOVD</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RNASEH2C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RNASEH2C</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RNASEH2C[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RNASEH2C</a></td></tr><tr><td headers="hd_b_ags.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/25939" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SAMHD1</i></a></td><td headers="hd_b_ags.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=25939" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20q11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y3Z3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Deoxynucleoside triphosphate triphosphohydrolase SAMHD1</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_ags.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SAMHD1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SAMHD1</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SAMHD1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SAMHD1</a></td></tr><tr><td headers="hd_b_ags.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/11277" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TREX1</i></a></td><td headers="hd_b_ags.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=11277" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p21<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Three prime repair exonuclease 1</td><td headers="hd_b_ags.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/TREX1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Three prime repair exonuclease 1 (TREX1) @ LOVD</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TREX1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TREX1</a></td><td headers="hd_b_ags.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TREX1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TREX1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ags.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ags.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Aicardi-Goutieres Syndrome (<a href="/omim/146920,225750,606034,606609,606754,606951,610181,610326,610329,610330,610333,612952,615010,615846" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/146920" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">146920</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADENOSINE DEAMINASE, RNA-SPECIFIC; ADAR</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/225750" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">225750</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AICARDI-GOUTIERES SYNDROME 1; AGS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606034" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606034</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RIBONUCLEASE H2, SUBUNIT A; RNASEH2A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606609" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606609</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3-PRIME @REPAIR EXONUCLEASE 1; TREX1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606754" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606754</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SAM DOMAIN- AND HD DOMAIN-CONTAINING PROTEIN 1; SAMHD1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606951" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606951</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">INTERFERON-INDUCED HELICASE C DOMAIN-CONTAINING PROTEIN 1; IFIH1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610181" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610181</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AICARDI-GOUTIERES SYNDROME 2; AGS2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610326" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610326</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RIBONUCLEASE H2, SUBUNIT B; RNASEH2B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610329" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610329</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AICARDI-GOUTIERES SYNDROME 3; AGS3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610330" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610330</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RIBONUCLEASE H2, SUBUNIT C; RNASEH2C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610333" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610333</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AICARDI-GOUTIERES SYNDROME 4; AGS4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612952" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612952</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AICARDI-GOUTIERES SYNDROME 5; AGS5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615010" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615010</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AICARDI-GOUTIERES SYNDROME 6; AGS6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615846" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615846</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AICARDI-GOUTIERES SYNDROME 7; AGS7</td></tr></tbody></table></div></div><p><b><i>ADAR</i></b></p><p><b>Gene structure.</b>
<i>ADAR</i> is a single-copy 16-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> that encodes two main <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> constitutively expressed in mammalian cells: a truncated protein (p110 <a href="/protein/NP_001020278.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001020278.1</a>) encoded by a transcript variant of 15 exons (<a href="/nuccore/NM_001025107.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001025107.2</a>) and an IFN inducible full-length protein (p150 <a href="/protein/NP_001102.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001102.2</a>) induced isoform encoded by transcript variant <a href="/nuccore/NM_001111.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001111.4</a>. For a detailed summary of gene and protein information, see <a href="/books/NBK1475/#ags.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of pathogenic variants in <i>ADAR</i> result in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disease. Missense, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> pathogenic variants have been reported. One <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant, p.Pro193Ala, is common in individuals of European origin. One dominant variant, p.Gly1007Arg, has been reported [<a class="bk_pop" href="#ags.REF.rice.2012.1243">Rice et al 2012</a>, <a class="bk_pop" href="#ags.REF.livingston.2014a.76">Livingston et al 2014a</a>].</p><div id="ags.T.selected_adar_pathogenic_variants" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>ADAR</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.T.selected_adar_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.T.selected_adar_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ags.T.selected_adar_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ags.T.selected_adar_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ags.T.selected_adar_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ags.T.selected_adar_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.577C&#x0003e;G</td><td headers="hd_h_ags.T.selected_adar_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro193Ala</td><td headers="hd_h_ags.T.selected_adar_pathogenic_variants_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001111.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001111<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_001102.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001102<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_ags.T.selected_adar_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3019G&#x0003e;A</td><td headers="hd_h_ags.T.selected_adar_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1007Arg</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> DRADA, double-stranded RNA-specific adenosine deaminase, is a modular protein with a C-terminal deaminase catalytic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, three centrally located dsRNA-binding domains (dsRBDs) and one or two N-terminal Z-DNA&#x02013;binding domains; compared with p110, the p150 isoform of human DRADA possesses an additional 295 N-terminal amino acids containing a nuclear export signal and an extra Z-DNA/Z-RNA-binding domain.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>ADAR</i> are believed to cause AGS as a result of loss of protein activity; the precise mechanism leading to disease is unclear.</p><p><b><i>IFIH1</i></b></p><p><b>Gene structure.</b>
<i>IFIH1</i> has 16 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1475/#ags.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> All <i>IFIH1</i> pathogenic variants associated with AGS to date have been <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that cause dominant disease.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>IFIH1</i> encodes the interferon-induced helicase C <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-containing protein 1, a cytosolic double-stranded RNA receptor.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>IHIF1</i> associated with AGS encode <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that cause up-regulation of type I interferon signaling [<a class="bk_pop" href="#ags.REF.rice.2014.503">Rice et al 2014</a>].</p><p><b><i>RNASEH2A</i></b></p><p><b>Gene structure.</b>
<i>RNASEH2A</i> has eight exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1475/#ags.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of pathogenic variants in <i>RNASEH2A</i> are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>; <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> and frameshift pathogenic variants have also been reported [<a class="bk_pop" href="#ags.REF.crow.2006b.910">Crow et al 2006b</a>, <a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>] (see <a class="figpopup" href="/books/NBK1475/table/ags.T.selected_rnaseh2a_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figagsTselectedrnaseh2apathogenicvaria" rid-ob="figobagsTselectedrnaseh2apathogenicvaria">Table 5</a>).</p><div id="ags.T.selected_rnaseh2a_pathogenic_varia" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Selected <i>RNASEH2A</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.T.selected_rnaseh2a_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.T.selected_rnaseh2a_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change&#x000a0;<sup>1</sup></th><th id="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.69G&#x0003e;A&#x000a0;<sup>2</sup></td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val23=</td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_3" rowspan="11" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=38455390" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006397<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=38455391" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006388<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.75C&#x0003e;T&#x000a0;<sup>2</sup></td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg25=</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.109G&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly37Ser</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.207_208insG</td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr69AspfsTer50</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.322C&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg108Trp</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.556C&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg186Trp</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.690C&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe231Leu</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.704G&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg236Gln</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.716_717dupGC</td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr239AlafsTer77</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.719C&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr241Met</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.872G&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg292His</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="ags.TF.5.1"><p class="no_margin">Frequency of each <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is less than 1%.</p></div></dd><dt>2. </dt><dd><div id="ags.TF.5.2"><p class="no_margin">Two synonymous variants (c.69G&#x0003e;A and c.75C&#x0003e;T) in <i>RNASEH2A</i> are pathogenic due to an alteration in RNA <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> [<a class="bk_pop" href="#ags.REF.rice.2013b.1066">Rice et al 2013b</a>].</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>RNASEH2A</i> encodes the ribonuclease H2 subunit A, which comprises 299 amino acids. Ribonuclease H (RNASEH) enzymes endonucleolytically cleave ribonucleotides from RNA:DNA duplexes. RNASEH<i>2</i> has been proposed to function in the removal of lagging strand Okazaki fragment RNA primers during DNA replication, as well as in the excision of single ribonucleotides from DNA:DNA duplexes. However, the precise biologic function of the human RNASEH2 complex in the context of AGS is uncertain.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> See <b><i>RNASEH2B</i></b><i>,</i>
<b>Abnormal gene product</b>.</p><p><b><i>RNASEH2B</i></b></p><p><b>Gene structure.</b>
<i>RNASEH2B</i> has 11 exons and codes for a 308-amino acid protein. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1475/#ags.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Almost all pathogenic variants so far identified in <i>RNASEH2B</i> are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> [<a class="bk_pop" href="#ags.REF.crow.2006b.910">Crow et al 2006b</a>, <a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>] (see <a class="figpopup" href="/books/NBK1475/table/ags.T.selected_rnaseh2b_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figagsTselectedrnaseh2bpathogenicvaria" rid-ob="figobagsTselectedrnaseh2bpathogenicvaria">Table 6</a>).</p><p>The frequency of alleles identified in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is:</p><ul><li class="half_rhythm"><div>p.Ala177Thr (62%)</div></li><li class="half_rhythm"><div>p.Thr163Ile (7%)</div></li><li class="half_rhythm"><div>p.Val185Gly (7%)</div></li><li class="half_rhythm"><div>c.136+1delG (4%)</div></li><li class="half_rhythm"><div>Remaining alleles (&#x0003c;2%) [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>]</div></li></ul><div id="ags.T.selected_rnaseh2b_pathogenic_varia" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Selected <i>RNASEH2B</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.T.selected_rnaseh2b_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.T.selected_rnaseh2b_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.64+1G&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_3" rowspan="20" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=13375741" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_024570<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=13375742" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_078846<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.136+1delG</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.244+1G&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.436+1G&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.510+1G&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.128C&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro43His</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.132T&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys44Ter</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.172C&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln58Ter</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.179T&#x0003e;G</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu60Arg</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.218G&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp73Leu</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.247G&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly83Ser</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.257A&#x0003e;G</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His86Arg</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.412C&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu138Phe</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.476G&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser159Ile</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.485A&#x0003e;C</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys162Thr</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.488C&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr163Ile</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.529G&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala177Thr</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.547C&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val183Met</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.554T&#x0003e;G</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val185Gly</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.655T&#x0003e;C</td><td headers="hd_h_ags.T.selected_rnaseh2b_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr219His</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The precise function of the ribonuclease H2 subunit B protein within the human RNASEH2 complex is unknown.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in genes encoding any of the three subunits of the ribonuclease H2 complex are thought to cause AGS resulting from a loss of enzymatic function.</p><p><b><i>RNASEH2C</i></b></p><p><b>Gene structure.</b>
<i>RNASEH2C</i> is a four-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding a 164-amino acid protein. For a detailed summary of gene and protein information, see <a href="/books/NBK1475/#ags.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> All pathogenic variants so far identified in <i>RNASEH2C</i> are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> [<a class="bk_pop" href="#ags.REF.crow.2006b.910">Crow et al 2006b</a>, <a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>] (see <a class="figpopup" href="/books/NBK1475/table/ags.T.selected_rnaseh2c_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figagsTselectedrnaseh2cpathogenicvaria" rid-ob="figobagsTselectedrnaseh2cpathogenicvaria">Table 7</a>).</p><p>The frequency of alleles identified in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is:</p><ul><li class="half_rhythm"><div>p.Arg69Trp (72%)</div></li><li class="half_rhythm"><div>Remaining alleles (seen only in single families)</div></li></ul><div id="ags.T.selected_rnaseh2c_pathogenic_varia" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Selected <i>RNASEH2C</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.T.selected_rnaseh2c_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.T.selected_rnaseh2c_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.38G&#x0003e;A</td><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg13His</td><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_3" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=113204623" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_032193<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=38176285" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_115569<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.205C&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg69Trp</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.227C&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro76Leu</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.412C&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro138Leu</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.428A&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys143Ile</td></tr><tr><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.451C&#x0003e;T</td><td headers="hd_h_ags.T.selected_rnaseh2c_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro151Ser</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The function of ribonuclease H2 subunit C (RNASEH2C) within the RNASEH2 complex is unknown.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> See <b><i>RNASEH2B</i></b><i>,</i>
<b>Abnormal gene product</b>.</p><p><b><i>SAMHD1</i></b></p><p><b>Gene structure.</b>
<i>SAMHD1</i> has 16 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1475/#ags.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, or frameshift variants [<a class="bk_pop" href="#ags.REF.rice.2009.829">Rice et al 2009</a>].</p><p>Three large deletions plus a small <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have also been identified. A large deletion of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 is common among individuals of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> descent [<a class="bk_pop" href="#ags.REF.crow.2015.296">Crow et al 2015</a>].</p><div id="ags.T.selected_samhd1_pathogenic_variant" class="table"><h3><span class="label">Table 8. </span></h3><div class="caption"><p>Selected <i>SAMHD1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.T.selected_samhd1_pathogenic_variant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.T.selected_samhd1_pathogenic_variant_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.359_370del12</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp120_His123del</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_3" rowspan="21" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_015474.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015474<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_056289.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_056289<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.368A&#x0003e;C</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His123Pro</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.427C&#x0003e;T</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg143Cys</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.428G&#x0003e;A</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg143His</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.433C&#x0003e;T</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg145Ter</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.434G&#x0003e;A</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg145Gln</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.445C&#x0003e;T</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln149Ter</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.602T&#x0003e;A</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile201Asn</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.625G&#x0003e;A</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly209Ser</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.649_650insG</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe217CysTer2</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.760A&#x0003e;G</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met254Val</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1106T&#x0003e;C</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu369Ser</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1153A&#x0003e;G</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met385Val</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1324C&#x0003e;T</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg442Ter</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1411-2A&#x0003e;G</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(splice acceptor)</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1503+1G&#x0003e;T</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(splice donor)</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1642C&#x0003e;T</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln548Ter</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1609-1G&#x0003e;C</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(splice acceptor)</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(exons 12-16del)</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(8984bp promoter+ex1del)</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(exons 1-13del)</td><td headers="hd_h_ags.T.selected_samhd1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="ags.TF.8.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> SAMHD1 is a 626-amino acid protein that consists of a SAM <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and an HD domain; the protein acts as a dNTP triphosphohydrolase [<a class="bk_pop" href="#ags.REF.goldstone.2011.379">Goldstone et al 2011</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>SAMHD1</i> are believed to cause AGS as a result of mislocalization of the protein or loss of protein function.</p><p><b><i>TREX1</i> (<i>AGS1</i>)</b></p><p><b>Gene structure.</b>
<i>TREX1</i> has one <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1475/#ags.molgen.TA">Table A</a>, <b>Gene</b>.</p><p>Note: A great deal of confusion regarding <i>TREX1</i> and the overlapping <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>ATRIP</i> exists in the databases. <i>TREX1</i> and <i>ATRIP</i> are distinct genes that encode distinct proteins; they are not known to be relevant to one another [<a class="bk_pop" href="#ags.REF.yang.2007.873">Yang et al 2007</a>].</p><p><b>Pathogenic variants.</b> Stop variants, deletions, and insertions are common in <i>TREX1</i>, but the most prevalent <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (p.Arg114His) that affects the dimerization of the TREX1 protein (3' repair exonuclease 1) and is likely to be a functional <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. The pathogenic variant p.Arg114His is particularly common in people from northern Europe.</p><p>Affected individuals are almost always homozygotes or compound heterozygotes for pathogenic variants within the same <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. However, children with clinically typical AGS had a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TREX1</i> [<a class="bk_pop" href="#ags.REF.rice.2007a.811">Rice et al 2007a</a>, <a class="bk_pop" href="#ags.REF.haaxma.2010.2612">Haaxma et al 2010</a>, <a class="bk_pop" href="#ags.REF.abe.2014.448">Abe et al 2014</a>] (see <a class="figpopup" href="/books/NBK1475/table/ags.T.selected_trex1_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figagsTselectedtrex1pathogenicvariants" rid-ob="figobagsTselectedtrex1pathogenicvariants">Table 9</a>).</p><p>The frequency of alleles identified in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is [<a class="bk_pop" href="#ags.REF.rice.2007b.713">Rice et al 2007b</a>]:</p><ul><li class="half_rhythm"><div>p.Arg114His (50%)</div></li><li class="half_rhythm"><div>c.58_59insG (1%)</div></li><li class="half_rhythm"><div>Remaining alleles (&#x0003c;1%)</div></li></ul><div id="ags.T.selected_trex1_pathogenic_variants" class="table"><h3><span class="label">Table 9. </span></h3><div class="caption"><p>Selected <i>TREX1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1475/table/ags.T.selected_trex1_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ags.T.selected_trex1_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.52G&#x0003e;A</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp18Asn</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_3" rowspan="17" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=12751315" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AAK07616<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=12751314" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AF319569<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.58_59insG</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu20GlyfsTer81</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.212_213dupTG</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala72Trpfster16</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.341G&#x0003e;A</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg114His</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.365T&#x0003e;C</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val122Ala</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.366_368dupGGC</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala123dup</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.397delC</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu133CysfsTer26</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.393_408dup16</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu137ProfsTer23</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.490C&#x0003e;T</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg164Ter</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.500delG</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser166ThrfsTer12</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.598G&#x0003e;T</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp200Asn</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.600_601insGAT</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp200dup</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.602T&#x0003e;A</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val201Asp</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.609_662dup54</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu204_Ala221dup</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.625_628dupCAGT</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp210SerfsTer31</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.868_885del18</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro289_Ala294del</td></tr><tr><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.907A&#x0003e;C</td><td headers="hd_h_ags.T.selected_trex1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr303Pro</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>TREX1</i> is a single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> gene encoding a 314-amino acid residue protein.</p><p>TREX1 protein represents the major 3'&#x02192;5' DNA exonuclease activity measured in mammalian cells. The protein has three conserved sequence motifs known as Exo I, II, and III. These motifs contain four conserved acidic residues that participate in coordination of divalent metal ions required for catalysis. In addition, the protein contains a C-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of about 75 amino acids, which is probably involved in subcellular localization of the protein, and a polyproline motif that may be involved in the interaction with other proteins. <i>TREX1</i> appears to play a role in the disposal of single-stranded DNA possibly produced as a normal replication intermediate during S phase [<a class="bk_pop" href="#ags.REF.yang.2007.873">Yang et al 2007</a>], or derived from retro-elements [<a class="bk_pop" href="#ags.REF.stetson.2008.587">Stetson et al 2008</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The most prevalent <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TREX1</i> is a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> change (p.Arg114His) that affects the dimerization of the TREX1 protein (3' repair exonuclease 1) and is likely to be a functional <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, as are other reported frameshift variants.</p></div><div id="ags.References"><h2 id="_ags_References_">References</h2><div id="ags.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ags.REF.abdelsalam.2008.2929">Abdel-Salam GM, Zaki MS, Saleem SN, Gaber KR. Microcephaly, malformation of brain development and intracranial calcification in sibs: pseudo-TORCH or a new syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:2929–36.</span> [<a href="/pubmed/18925673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18925673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.abe.2013.406">Abe J, Izawa K, Nishikomori R, Awaya T, Kawai T, Yasumi T, Hiragi N, Hiragi T, Ohshima Y, Heike T. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus. <span><span class="ref-journal">Rheumatology (Oxford). </span>2013;<span class="ref-vol">52</span>:406–8.</span> [<a href="/pubmed/22829693" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22829693</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.abe.2014.448">Abe J, Nakamura K, Nishikomori R, Kato M, Mitsuiki N, Izawa K, Awaya T, Kawai T, Yasumi T, Toyoshima I, Hasegawa K, Ohshima Y, Hiragi T, Sasahara Y, Suzuki Y, Kikuchi M, Osaka H, Ohya T, Ninomiya S, Fujikawa S, Akasaka M, Iwata N, Kawakita A, Funatsuka M, Shintaku H, Ohara O, Ichinose H, Heike T. A nationwide survey of Aicardi-Goutieres syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study. <span><span class="ref-journal">Rheumatology (Oxford). </span>2014;<span class="ref-vol">53</span>:448–58.</span> [<a href="/pubmed/24300241" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24300241</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.aicardi.1984.49">Aicardi J, Gouti&#x000e8;res F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. <span><span class="ref-journal">Ann Neurol. </span>1984;<span class="ref-vol">15</span>:49–54.</span> [<a href="/pubmed/6712192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6712192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.aicardi.2000.113">Aicardi J, Gouti&#x000e8;res F. Systemic lupus erythematosus or Aicardi-Goutieres syndrome? <span><span class="ref-journal">Neuropediatrics. </span>2000;<span class="ref-vol">31</span>:113.</span> [<a href="/pubmed/10963096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10963096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.anderson.2012.338">Anderson BH, Kasher PR, Mayer J, Szynkiewicz M, Jenkinson EM, Bhaskar SS, Urquhart JE, Daly SB, Dickerson JE, O'Sullivan J, Leibundgut EO, Muter J, Abdel-Salem GM, Babul-Hirji R, Baxter P, Berger A, Bonaf&#x000e9; L, Brunstom-Hernandez JE, Buckard JA, Chitayat D, Chong WK, Cordelli DM, Ferreira P, Fluss J, Forrest EH, Franzoni E, Garone C, Hammans SR, Houge G, Hughes I, Jacquemont S, Jeannet PY, Jefferson RJ, Kumar R, Kutschke G, Lundberg S, Louren&#x000e7;o CM, Mehta R, Naidu S, Nischal KK, Nunes L, Ounap K, Philippart M, Prabhakar P, Risen SR, Schiffmann R, Soh C, Stephenson JB, Stewart H, Stone J, Tolmie JL, van der Knaap MS, Vieira JP, Vilain CN, Wakeling EL, Wermenbol V, Whitney A, Lovell SC, Meyer S, Livingston JH, Baerlocher GM, Black GC, Rice GI, Crow YJ. Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:338–42.</span> [<a href="/pubmed/22267198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22267198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.barth.2002">Barth PG (2002) The neuropathology of Aicardi-Goutieres syndrome. Eur J Paediatr Neurol. 6 Suppl A:A27-31. [<a href="/pubmed/12365358" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12365358</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.blau.2003.642">Blau N, Bonafe L, Krageloh-Mann I, Thony B, Kierat L, Hausler M, Ramaekers V. Cerebrospinal fluid pterins and folates in Aicardi-Goutieres syndrome: a new phenotype. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:642–7.</span> [<a href="/pubmed/12963755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12963755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.briggs.2008.3173">Briggs TA, Wolf NI, D'Arrigo S, Ebinger F, Harting I, Dobyns WB, Livingston JH, Rice GI, Crooks D, Rowland-Hill CA, Squier W, Stoodley N, Pilz DT, Crow YJ. Band-like intracranial calcification with simplified gyration and polymicrogyria: a distinct "pseudo-TORCH" phenotype. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:3173–80.</span> [<a href="/pubmed/19012351" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19012351</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.chitayat.1992.86">Chitayat D, Meagher-Villemure K, Mamer OA, O'Gorman A, Hoar DI, Silver K, Scriver CR. Brain dysgenesis and congenital intracerebral calcification associated with 3-hydroxyisobutyric aciduria. <span><span class="ref-journal">J Pediatr. </span>1992;<span class="ref-vol">121</span>:86–9.</span> [<a href="/pubmed/1625099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1625099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.crow.2003.183">Crow YJ, Black DN, Ali M, Bond J, Jackson AP, Lefson M, Michaud J, Roberts E, Stephenson JB, Woods CG, Lebon P. Cree encephalitis is allelic with Aicardi-Goutieres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:183–7.</span> [<a href="/pmc/articles/PMC1735395/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735395</span></a>] [<a href="/pubmed/12624136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12624136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.crow.2015.296">Crow YJ, Chase DS, Lowenstein Schmidt J, Szynkiewicz M, Forte GM, Gornall HL, Oojageer A, Anderson B, Pizzino A, Helman G, Abdel-Hamid MS, Abdel-Salam GM, Ackroyd S, Aeby A, Agosta G, Albin C, Allon-Shalev S, Arellano M, Ariaudo G, Aswani V, Babul-Hirji R, Baildam EM, Bahi-Buisson N, Bailey KM, Barnerias C, Barth M, Battini R, Beresford MW, Bernard G, Bianchi M, Billette de Villemeur T, Blair EM, Bloom M, Burlina AB, Carpanelli ML, Carvalho DR, Castro-Gago M, Cavallini A, Cereda C, Chandler KE, Chitayat DA, Collins AE, Sierra Corcoles C, Cordeiro NJ, Crichiutti G, Dabydeen L, Dale RC, D'Arrigo S, De Goede CG, De Laet C, De Waele LM, Denzler I, Desguerre I, Devriendt K, Di Rocco M, Fahey MC, Fazzi E, Ferrie CD, Figueiredo A, Gener B, Goizet C, Gowrinathan NR, Gowrishankar K, Hanrahan D, Isidor B, Kara B, Khan N, King MD, Kirk EP, Kumar R, Lagae L, Landrieu P, Lauffer H, Laugel V, La Piana R, Lim MJ, Lin JP, Linnankivi T, Mackay MT, Marom DR, Marques Louren&#x000e7;o C, McKee SA, Moroni I, Morton JE, Moutard ML, Murray K, Nabbout R, Nampoothiri S, Nunez-Enamorado N, Oades PJ, Olivieri I, Ostergaard JR, P&#x000e9;rez-Due&#x000f1;as B, Prendiville JS, Ramesh V, Rasmussen M, R&#x000e9;gal L, Ricci F, Rio M, Rodriguez D, Roubertie A, Salvatici E, Segers KA, Sinha GP, Soler D, Spiegel R, St&#x000f6;dberg TI, Straussberg R, Swoboda KJ, Suri M, Tacke U, Tan TY, te Water Naude J, Wee Teik K, Thomas MM, Till M, Tonduti D, Valente EM, Van Coster RN, van der Knaap MS, Vassallo G, Vijzelaar R, Vogt J, Wallace GB, Wassmer E, Webb HJ, Whitehouse WP, Whitney RN, Zaki MS, Zuberi SM, Livingston JH, Rozenberg F, Lebon P, Vanderver A, Orcesi S, Rice GI. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. <span><span class="ref-journal">Am J Med Genet A. </span>2015;2015;<span class="ref-vol">167A</span>:296–312.</span> [<a href="/pmc/articles/PMC4382202/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4382202</span></a>] [<a href="/pubmed/25604658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25604658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.crow.2006a.917">Crow YJ, Hayward BE, Parmar R, Robins P, Leitch A, Ali M, Black DN, van Bokhoven H, Brunner HG, Hamel BC, Corry PC, Cowan FM, Frints SG, Klepper J, Livingston JH, Lynch SA, Massey RF, Meritet JF, Michaud JL, Ponsot G, Voit T, Lebon P, Bonthron DT, Jackson AP, Barnes DE, Lindahl T. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. <span><span class="ref-journal">Nat Genet. </span>2006a;<span class="ref-vol">38</span>:917–20.</span> [<a href="/pubmed/16845398" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16845398</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.crow.2006b.910">Crow YJ, Leitch A, Hayward BE, Garner A, Parmar R, Griffith E, Ali M, Semple C, Aicardi J, Babul-Hirji R, Baumann C, Baxter P, Bertini E, Chandler KE, Chitayat D, Cau D, Dery C, Fazzi E, Goizet C, King MD, Klepper J, Lacombe D, Lanzi G, Lyall H, Martinez-Frias ML, Mathieu M, McKeown C, Monier A, Oade Y, Quarrell OW, Rittey CD, Rogers RC, Sanchis A, Stephenson JB, Tacke U, Till M, Tolmie JL, Tomlin P, Voit T, Weschke B, Woods CG, Lebon P, Bonthron DT, Ponting CP, Jackson AP. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. <span><span class="ref-journal">Nat Genet. </span>2006b;<span class="ref-vol">38</span>:910–6.</span> [<a href="/pubmed/16845400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16845400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.crow.2004a.303">Crow YJ, Massey RF, Innes JR, Pairaudeau PW, Rowland Hill CA, Woods CG, Ali M, Livingston JH, Lebon P, Nischall K, McEntagart M, Hindocha N, Winter RM. Congenital glaucoma and brain stem atrophy as features of Aicardi-Goutieres syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2004a;<span class="ref-vol">129A</span>:303–7.</span> [<a href="/pubmed/15326633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15326633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.crow.2004b.10">Crow YJ, McMenamin J, Haenggeli CA, Hadley DM, Tirupathi S, Treacy EP, Zuberi SM, Browne BH, Tolmie JL, Stephenson JB. Coats' plus: a progressive familial syndrome of bilateral Coats' disease, characteristic cerebral calcification, leukoencephalopathy, slow pre- and post-natal linear growth and defects of bone marrow and integument. <span><span class="ref-journal">Neuropediatrics. </span>2004b;<span class="ref-vol">35</span>:10–9.</span> [<a href="/pubmed/15002047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15002047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.crow.2009.r130">Crow YJ, Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:R130–6.</span> [<a href="/pmc/articles/PMC2758706/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2758706</span></a>] [<a href="/pubmed/19808788" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19808788</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.crow.2014.1">Crow YJ, Vanderver A, Orcesi S, Kuijpers TW, Rice GI. Therapies in Aicardi-Gouti&#x000e8;res syndrome. <span><span class="ref-journal">Clin Exp Immunol. </span>2014;<span class="ref-vol">175</span>:1–8.</span> [<a href="/pmc/articles/PMC3898548/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3898548</span></a>] [<a href="/pubmed/23607857" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23607857</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.crow.2014a.386">Crow YJ, Zaki MS, Abdel-Hamid MS, Abdel-Salam G, Boespflug-Tanguy O, Cordeiro NJ, Gleeson JG, Gowrinathan NR, Laugel V, Renaldo F, Rodriguez D, Livingston JH, Rice GI. Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia. <span><span class="ref-journal">Neuropediatrics. </span>2014a;<span class="ref-vol">45</span>:386–93.</span> [<a href="/pubmed/25243380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25243380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.dale.2010.938">Dale RC, Gornall H, Singh-Grewal D, Alcausin M, Rice GI, Crow YJ. Familial Aicardi-Gouti&#x000e8;res syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:938–42.</span> [<a href="/pubmed/20358604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20358604</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.dale.2000.155">Dale RC, Tang SP, Heckmatt JZ, Tatnall FM. Familial systemic lupus erythematosus and congenital infection-like syndrome. <span><span class="ref-journal">Neuropediatrics. </span>2000;<span class="ref-vol">31</span>:155–8.</span> [<a href="/pubmed/10963105" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10963105</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.desanges.2006.153">Desanges C, Lebon P, Bauman C, Vuillard E, Garel C, Cordesse A, Oury JF, Crow Y, Luton D. Elevated interferon-alpha in fetal blood in the prenatal diagnosis of Aicardi-Goutieres syndrome. <span><span class="ref-journal">Fetal Diagn Ther. </span>2006;<span class="ref-vol">21</span>:153–5.</span> [<a href="/pubmed/16354995" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16354995</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.du_moulin.2011.e232">du Moulin M, N&#x000fc;rnberg P, Crow YJ, Rutsch F. Cerebral vasculopathy is a common feature in Aicardi-Goutieres syndrome associated with SAMHD1 mutations. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2011;<span class="ref-vol">108</span>:E232.</span> [<a href="/pmc/articles/PMC3127916/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3127916</span></a>] [<a href="/pubmed/21633013" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21633013</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.gardner.2005.362">Gardner RJ, Chow CW, Simpson I, Fink AM, Meagher SE, White SM. Severe fetal brain dysgenesis with focal calcification. <span><span class="ref-journal">Prenat Diagn. </span>2005;<span class="ref-vol">25</span>:362–4.</span> [<a href="/pubmed/15906425" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15906425</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.goldstone.2011.379">Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de Carvalho LP, Stoye JP, Crow YJ, Taylor IA, Webb M. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. <span><span class="ref-journal">Nature. </span>2011;<span class="ref-vol">480</span>:379–82.</span> [<a href="/pubmed/22056990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22056990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.gouti_res.1998.900">Gouti&#x000e8;res F, Aicardi J, Barth PG, Lebon P. Aicardi-Goutieres syndrome: an update and results of interferon-alpha studies. <span><span class="ref-journal">Ann Neurol. </span>1998;<span class="ref-vol">44</span>:900–7.</span> [<a href="/pubmed/9851434" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9851434</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.haaxma.2010.2612">Haaxma CA, Crow YJ, van Steensel MA, Lammens MM, Rice GI, Verbeek MM, Willemsen MA. A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Gouti&#x000e8;res syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:2612–7.</span> [<a href="/pubmed/20799324" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20799324</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.knoblauch.2003.261">Knoblauch H, Tennstedt C, Brueck W, Hammer H, Vulliamy T, Dokal I, Lehmann R, Hanefeld F, Tinschert S. Two brothers with findings resembling congenital intrauterine infection-like syndrome (pseudo-TORCH syndrome). <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">120A</span>:261–5.</span> [<a href="/pubmed/12833411" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12833411</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.kondo.2008.662">Kondo T, Suzuki T, Ito S, Kono M, Negoro T, Tomita Y. Dyschromatosis symmetrica hereditaria associated with neurological disorders. <span><span class="ref-journal">J Dermatol. </span>2008;<span class="ref-vol">35</span>:662–6.</span> [<a href="/pubmed/19017046" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19017046</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.kumar.1998.508">Kumar D, Rittey C, Cameron AH, Variend S. Recognizable inherited syndrome of progressive central nervous system degeneration and generalized intracranial calcification with overlapping phenotype of the syndrome of Aicardi and Goutieres. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">75</span>:508–15.</span> [<a href="/pubmed/9489795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9489795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.la_piana.2014.815">La Piana R, Uggetti C, Olivieri I, Tonduti D, Balottin U, Fazzi E, Orcesi S. Bilateral striatal necrosis in two subjects with Aicardi-Gouti&#x000e8;res syndrome due to mutations in ADAR1 (AGS6). <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:815–9.</span> [<a href="/pubmed/24376015" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24376015</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.lanzi.2002.a9">Lanzi G, Fazzi E, D'Arrigo S. Aicardi-Goutieres syndrome: a description of 21 new cases and a comparison with the literature. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2002;<span class="ref-vol">6</span>:A9–A22.</span> [<a href="/pubmed/12365365" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12365365</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.lanzi.2005.1621">Lanzi G, Fazzi E, D'Arrigo S, Orcesi S, Maraucci I, Uggetti C, Bertini E, Lebon P. The natural history of Aicardi-Goutieres syndrome: follow-up of 11 Italian patients. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:1621–4.</span> [<a href="/pubmed/15883328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15883328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.le_garrec.2005.28">Le Garrec M, Doret M, Pasquier JC, Till M, Lebon P, Buenerd A, Escalon J, Gaucherand P. Prenatal diagnosis of Aicardi-Goutieres syndrome. <span><span class="ref-journal">Prenat Diagn. </span>2005;<span class="ref-vol">25</span>:28–30.</span> [<a href="/pubmed/15662687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15662687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.leekirsch.2007a.531">Lee-Kirsch MA, Chowdhury D, Harvey S, Gong M, Senenko L, Engel K, Pfeiffer C, Hollis T, Gahr M, Perrino FW, Lieberman J, Hubner N. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. <span><span class="ref-journal">J Mol Med. </span>2007a;<span class="ref-vol">85</span>:531–7.</span> [<a href="/pubmed/17440703" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17440703</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.leekirsch.2007b.1065">Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, de Silva U, Bailey SL, Witte T, Vyse TJ, Kere J, Pfeiffer C, Harvey S, Wong A, Koskenmies S, Hummel O, Rohde K, Schmidt RE, Dominiczak AF, Gahr M, Hollis T, Perrino FW, Lieberman J, Hubner N. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. <span><span class="ref-journal">Nat Genet. </span>2007b;<span class="ref-vol">39</span>:1065–7.</span> [<a href="/pubmed/17660818" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17660818</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.linnankivi.2006.1437">Linnankivi T, Valanne L, Paetau A, Alafuzoff I, Hakumaki JM, Kivela T, Lonnqvist T, Makitie O, Paakkonen L, Vainionpaa L, Vanninen R, Herva R, Pihko H. Cerebroretinal microangiopathy with calcifications and cysts. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:1437–43.</span> [<a href="/pubmed/16943371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16943371</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.livingston.2014a.76">Livingston JH, Lin JP, Dale RC, Gill D, Brogan P, Munnich A, Kurian MA, Gonzalez-Martinez V, De Goede CG, Falconer A, Forte G, Jenkinson EM, Kasher PR, Szynkiewicz M, Rice GI, Crow YJ. A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1. <span><span class="ref-journal">J Med Genet. </span>2014a;<span class="ref-vol">51</span>:76–82.</span> [<a href="/pubmed/24262145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24262145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.livingston.2014b.175">Livingston JH, Mayer J, Jenkinson E, Kasher P, Stivaros S, Berger A, Cordelli DM, Ferreira P, Jefferson R, Kutschke G, Lundberg S, Ounap K, Prabhakar P, Soh C, Stewart H, Stone J, van der Knaap MS, van Esch H, van Mol C, Wakeling E, Whitney A, Rice GI, Crow YJ. Leukoencephalopathy with calcifications and cysts: a purely neurological disorder distinct from Coats plus. <span><span class="ref-journal">Neuropediatrics. </span>2014b;<span class="ref-vol">45</span>:175–82.</span> [<a href="/pubmed/24407470" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24407470</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.livingston.2013.46">Livingston JH, Stivaros S, van der Knaap MS, Crow YJ. Recognizable phenotypes associated with intracranial calcification. <span><span class="ref-journal">Dev Med Child Neurol. </span>2013;<span class="ref-vol">55</span>:46–57.</span> [<a href="/pubmed/23121296" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23121296</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.mcentagart.1998.163">McEntagart M, Kamel H, Lebon P, King MD. Aicardi-Goutieres syndrome: an expanding phenotype. <span><span class="ref-journal">Neuropediatrics. </span>1998;<span class="ref-vol">29</span>:163–7.</span> [<a href="/pubmed/9706629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9706629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.odriscoll.2010.354">O'Driscoll MC, Daly SB, Urquhart JE, Black GC, Pilz DT, Brockmann K, McEntagart M, Abdel-Salam G, Zaki M, Wolf NI, Ladda RL, Sell S, D'Arrigo S, Squier W, Dobyns WB, Livingston JH, Crow YJ. Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:354–64.</span> [<a href="/pmc/articles/PMC2933344/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2933344</span></a>] [<a href="/pubmed/20727516" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20727516</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.prendiville.2003.60">Prendiville JS, Cabral DA, Poskitt KJ, Au S, Sargent MA. Central nervous system involvement in neonatal lupus erythematosus. <span><span class="ref-journal">Pediatr Dermatol. </span>2003;<span class="ref-vol">20</span>:60–7.</span> [<a href="/pubmed/12558850" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12558850</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.ramantani.2010.1469">Ramantani G, Kohlhase J, Hertzberg C, Innes AM, Engel K, Hunger S, Borozdin W, Mah JK, Ungerath K, Walkenhorst H, Richardt HH, Buckard J, Bevot A, Siegel C, von St&#x000fc;lpnagel C, Ikonomidou C, Thomas K, Proud V, Niemann F, Wieczorek D, H&#x000e4;usler M, Niggemann P, Baltaci V, Conrad K, Lebon P, Lee-Kirsch MA. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Gouti&#x000e8;res syndrome. <span><span class="ref-journal">Arthritis Rheum. </span>2010;<span class="ref-vol">62</span>:1469–77.</span> [<a href="/pubmed/20131292" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20131292</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.ramesh.2010.725">Ramesh V, Bernardi B, Stafa A, Garone C, Franzoni E, Abinun M, Mitchell P, Mitra D, Friswell M, Nelson J, Shalev SA, Rice GI, Gornall H, Szynkiewicz M, Aymard F, Ganesan V, Prendiville J, Livingston JH, Crow YJ. Intracerebral large artery disease in Aicardi-Gouti&#x000e8;res syndrome implicates SAMHD1 in vascular homeostasis. <span><span class="ref-journal">Dev Med Child Neurol. </span>2010;<span class="ref-vol">52</span>:725–32.</span> [<a href="/pubmed/20653736" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20653736</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.ravenscroft.2011.235">Ravenscroft JC, Suri M, Rice GI, Szynkiewicz M, Crow Y. Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:235–7.</span> [<a href="/pubmed/21204240" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21204240</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.reardon.1994.58">Reardon W, Hockey A, Silberstein P, Kendall B, Farag TI, Swash M, Stevenson R, Baraitser M. Autosomal recessive congenital intrauterine infection-like syndrome of microcephaly, intracranial calcification, and CNS disease. <span><span class="ref-journal">Am J Med Genet. </span>1994;<span class="ref-vol">52</span>:58–65.</span> [<a href="/pubmed/7977464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7977464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.rice.2007a.811">Rice G, Newman WG, Dean J, Patrick T, Parmar R, Flintoff K, Robins P, Harvey S, Hollis T, O'Hara A, Herrick AL, Bowden AP, Perrino FW, Lindahl T, Barnes DE, Crow YJ. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2007a;<span class="ref-vol">80</span>:811–5.</span> [<a href="/pmc/articles/PMC1852703/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1852703</span></a>] [<a href="/pubmed/17357087" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17357087</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.rice.2007b.713">Rice G, Patrick T, Parmar R, Taylor CF, Aeby A, Aicardi J, Artuch R, Montalto SA, Bacino CA, Barroso B, Baxter P, Benko WS, Bergmann C, Bertini E, Biancheri R, Blair EM, Blau N, Bonthron DT, Briggs T, Brueton LA, Brunner HG, Burke CJ, Carr IM, Carvalho DR, Chandler KE, Christen HJ, Corry PC, Cowan FM, Cox H, D'Arrigo S, Dean J, De Laet C, De Praeter C, Dery C, Ferrie CD, Flintoff K, Frints SG, Garcia-Cazorla A, Gener B, Goizet C, Goutieres F, Green AJ, Guet A, Hamel BC, Hayward BE, Heiberg A, Hennekam RC, Husson M, Jackson AP, Jayatunga R, Jiang YH, Kant SG, Kao A, King MD, Kingston HM, Klepper J, van der Knaap MS, Kornberg AJ, Kotzot D, Kratzer W, Lacombe D, Lagae L, Landrieu PG, Lanzi G, Leitch A, Lim MJ, Livingston JH, Lourenco CM, Lyall EG, Lynch SA, Lyons MJ, Marom D, McClure JP, McWilliam R, Melancon SB, Mewasingh LD, Moutard ML, Nischal KK, Ostergaard JR, Prendiville J, Rasmussen M, Rogers RC, Roland D, Rosser EM, Rostasy K, Roubertie A, Sanchis A, Schiffmann R, Scholl-Burgi S, Seal S, Shalev SA, Corcoles CS, Sinha GP, Soler D, Spiegel R, Stephenson JB, Tacke U, Tan TY, Till M, Tolmie JL, Tomlin P, Vagnarelli F, Valente EM, Van Coster RN, Van der Aa N, Vanderver A, Vles JS, Voit T, Wassmer E, Weschke B, Whiteford ML, Willemsen MA, Zankl A, Zuberi SM, Orcesi S, Fazzi E, Lebon P, Crow YJ. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2007b;<span class="ref-vol">81</span>:713–25.</span> [<a href="/pmc/articles/PMC2227922/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2227922</span></a>] [<a href="/pubmed/17846997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17846997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.rice.2009.829">Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA, Ali M, Gornall H, Couthard LR, Aeby A, Attard-Montalto SP, Bertini E, Bodemer C, Brockmann K, Brueton LA, Corry PC, Desguerre I, Fazzi E, Cazorla AG, Gener B, Hamel BC, Heiberg A, Hunter M, van der Knaap MS, Kumar R, Lagae L, Landrieu PG, Lourenco CM, Marom D, McDermott MF, van der Merwe W, Orcesi S, Prendiville JS, Rasmussen M, Shalev SA, Soler DM, Shinawi M, Spiegel R, Tan TY, Vanderver A, Wakeling EL, Wassmer E, Whittaker E, Lebon P, Stetson DB, Bonthron DT, Crow YJ. Mutations involved in Aicardi-Gouti&#x000e8;res syndrome implicate SAMHD1 as regulator of the innate immune response. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:829–32.</span> [<a href="/pmc/articles/PMC4154505/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4154505</span></a>] [<a href="/pubmed/19525956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19525956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.rice.2014.503">Rice GI, del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, Bader-Meunier B, Baildam EM, Battini R, Beresford MW, Casarano M, Chouchane M, Cimaz R, Collins AE, Cordeiro NJ, Dale RC, Davidson JE, De Waele L, Desguerre I, Faivre L, Fazzi E, Isidor B, Lagae L, Latchman AR. Lebon P2, Li C, Livingston JH, Louren&#x000e7;o CM, Mancardi MM, Masurel-Paulet A, McInnes IB, Menezes MP, Mignot C, O'Sullivan J, Orcesi S, Picco PP, Riva E, Robinson RA, Rodriguez D, Salvatici E, Scott C, Szybowska M, Tolmie JL, Vanderver A, Vanhulle C, Vieira JP, Webb K, Whitney RN, Williams SG, Wolfe LA, Zuberi SM, Hur S, Crow YJ. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. <span><span class="ref-journal">Nat Genet. </span>2014;<span class="ref-vol">46</span>:503–9.</span> [<a href="/pmc/articles/PMC4004585/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4004585</span></a>] [<a href="/pubmed/24686847" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24686847</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.rice.2013a.1159">Rice GI, Forte GM, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS, Ackroyd S, Allcock R, Bailey KM, Balottin U, Barnerias C, Bernard G, Bodemer C, Botella MP, Cereda C, Chandler KE, Dabydeen L, Dale RC, De Laet C, De Goede CG, Del Toro M, Effat L, Enamorado NN, Fazzi E, Gener B, Haldre M, Lin JP, Livingston JH, Lourenco CM, Marques W Jr, Oades P, Peterson P, Rasmussen M, Roubertie A, Schmidt JL, Shalev SA, Simon R, Spiegel R, Swoboda KJ, Temtamy SA, Vassallo G, Vilain CN, Vogt J, Wermenbol V, Whitehouse WP, Soler D, Olivieri I, Orcesi S, Aglan MS, Zaki MS, Abdel-Salam GM, Vanderver A, Kisand K, Rozenberg F, Lebon P, Crow YJ. Assessment of interferon-related biomarkers in Aicardi-Gouti&#x000e8;res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. <span><span class="ref-journal">Lancet Neurol. </span>2013a;<span class="ref-vol">12</span>:1159–69.</span> [<a href="/pmc/articles/PMC4349523/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4349523</span></a>] [<a href="/pubmed/24183309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24183309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.rice.2012.1243">Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA, Jenkinson EM, Bacino CA, Battini R, Bertini E, Brogan PA, Brueton LA, Carpanelli M, De Laet C, de Lonlay P, del Toro M, Desguerre I, Fazzi E, Garcia-Cazorla A, Heiberg A, Kawaguchi M, Kumar R, Lin JP, Lourenco CM, Male AM, Marques W Jr, Mignot C, Olivieri I, Orcesi S, Prabhakar P, Rasmussen M, Robinson RA, Rozenberg F, Schmidt JL, Steindl K, Tan TY, van der Merwe WG, Vanderver A, Vassallo G, Wakeling EL, Wassmer E, Whittaker E, Livingston JH, Lebon P, Suzuki T, McLaughlin PJ, Keegan LP, O'Connell MA, Lovell SC, Crow YJ. Mutations in ADAR1 cause Aicardi-Gouti&#x000e8;res syndrome associated with a type I interferon signature. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1243–8.</span> [<a href="/pmc/articles/PMC4154508/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4154508</span></a>] [<a href="/pubmed/23001123" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23001123</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.rice.2013b.1066">Rice GI, Reijns MA, Coffin SR, Forte GM, Anderson BH, Szynkiewicz M, Gornall H, Gent D, Leitch A, Botella MP, Fazzi E, Gener B, Lagae L, Olivieri I, Orcesi S, Swoboda KJ, Perrino FW, Jackson AP, Crow YJ. Synonymous mutations in RNASEH2A create cryptic splice sites impairing RNase H2 enzyme function in Aicardi-Gouti&#x000e8;res syndrome. <span><span class="ref-journal">Hum Mutat. </span>2013b;<span class="ref-vol">34</span>:1066–70.</span> [<a href="/pmc/articles/PMC3714325/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3714325</span></a>] [<a href="/pubmed/23592335" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23592335</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.rice.2015.235">Rice GI, Rodero MP, Crow YJ. Human disease phenotypes associated with mutations in TREX1. <span><span class="ref-journal">J Clin Immunol. </span>2015;<span class="ref-vol">35</span>:235–43.</span> [<a href="/pubmed/25731743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25731743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.richards.2007.1068">Richards A, van den Maagdenberg AM, Jen JC, Kavanagh D, Bertram P, Spitzer D, Liszewski MK, Barilla-Labarca ML, Terwindt GM, Kasai Y, McLellan M, Grand MG, Vanmolkot KR, de Vries B, Wan J, Kane MJ, Mamsa H, Schafer R, Stam AH, Haan J, de Jong PT, Storimans CW, van Schooneveld MJ, Oosterhuis JA, Gschwendter A, Dichgans M, Kotschet KE, Hodgkinson S, Hardy TA, Delatycki MB, Hajj-Ali RA, Kothari PH, Nelson SF, Frants RR, Baloh RW, Ferrari MD, Atkinson JP. C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:1068–70.</span> [<a href="/pubmed/17660820" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17660820</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.samson.1994.510">Samson JF, Barth PG, de Vries JI, Menko FH, Ruitenbeek W, van Oost BA, Jakobs C. Familial mitochondrial encephalopathy with fetal ultrasonographic ventriculomegaly and intracerebral calcifications. <span><span class="ref-journal">Eur J Pediatr. </span>1994;<span class="ref-vol">153</span>:510–6.</span> [<a href="/pubmed/7957369" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7957369</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.sanchis.2005.701">Sanchis A, Cervero L, Bataller A, Tortajada JL, Huguet J, Crow YJ, Ali M, Higuet LJ, Martinez-Frias ML. Genetic syndromes mimic congenital infections. <span><span class="ref-journal">J Pediatr. </span>2005;<span class="ref-vol">146</span>:701–5.</span> [<a href="/pubmed/15870678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15870678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.stephenson.2002">Stephenson JB (2002) Aicardi-Goutieres syndrome - observations of the Glasgow school. Eur J Paediatr Neurol 6 Suppl A:67-70. [<a href="/pubmed/12365363" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12365363</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.stetson.2008.587">Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. <span><span class="ref-journal">Cell. </span>2008;<span class="ref-vol">134</span>:587–98.</span> [<a href="/pmc/articles/PMC2626626/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2626626</span></a>] [<a href="/pubmed/18724932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18724932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.thiele.2010.e1836">Thiele H, du Moulin M, Barczyk K, George C, Schwindt W, N&#x000fc;rnberg G, Frosch M, Kurlemann G, Roth J, N&#x000fc;rnberg P, Rutsch F. Cerebral arterial stenoses and stroke: novel features of Aicardi-Gouti&#x000e8;res syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:E1836–50.</span> [<a href="/pmc/articles/PMC3049152/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3049152</span></a>] [<a href="/pubmed/20842748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20842748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.tojo.2006.1510">Tojo K, Sekijima Y, Suzuki T, Suzuki N, Tomita Y, Yoshida K, Hashimoto T, Ikeda S. Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation. <span><span class="ref-journal">Mov Disord. </span>2006;<span class="ref-vol">21</span>:1510–3.</span> [<a href="/pubmed/16817193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16817193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.tolmie.1995.881">Tolmie JL, Shillito P, Hughes-Benzie R, Stephenson JB. The Aicardi-Goutieres syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis). <span><span class="ref-journal">J Med Genet. </span>1995;<span class="ref-vol">32</span>:881–4.</span> [<a href="/pmc/articles/PMC1051740/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051740</span></a>] [<a href="/pubmed/8592332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8592332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.uggetti.2009.1971">Uggetti C, La Piana R, Orcesi S, Egitto MG, Crow YJ, Fazzi E. Aicardi-Goutieres syndrome: neuroradiologic findings and follow-up. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2009;<span class="ref-vol">30</span>:1971–6.</span> [<a href="/pubmed/19628626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19628626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.xin.2011.5372">Xin B, Jones S, Puffenberger EG, Hinze C, Bright A, Tan H, Zhou A, Wu G, Vargus-Adams J, Agamanolis D, Wang H. Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2011;<span class="ref-vol">108</span>:5372–7.</span> [<a href="/pmc/articles/PMC3069167/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3069167</span></a>] [<a href="/pubmed/21402907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21402907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ags.REF.yang.2007.873">Yang YG, Lindahl T, Barnes DE. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. <span><span class="ref-journal">Cell. </span>2007;<span class="ref-vol">131</span>:873–86.</span> [<a href="/pubmed/18045533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18045533</span></a>]</div></li></ul></div></div><div id="ags.Chapter_Notes"><h2 id="_ags_Chapter_Notes_">Chapter Notes</h2><div id="ags.Acknowledgments"><h3>Acknowledgments</h3><p>We would like to thank Dr Gillian Rice for her help in compiling the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> variant data.</p></div><div id="ags.Author_History"><h3>Author History</h3><p>Jean Aicardi, MD, FRCP; Hospital Robert-Debr&#x000e9;, Paris (2005-2014)<br />Yanick J Crow, MBBS, BMedSci, MRCP, PhD (2005-present)<br />John BP Stephenson, DM, FRCP, HonFRCPCH; Royal Hospital for Sick Children, Glasgow (2008-2014)</p></div><div id="ags.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>22 November 2016 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>13 March 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 March 2012 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/targeted-mutation-analysis/">targeted mutation analysis</a> for the c.490C&#x0003e;T mutation in <i>TREX1</i> available clinically</div></li><li class="half_rhythm"><div>19 January 2012 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically for <i>SAMHD1</i>, <i>TREX1</i>, <i>RNASEH2A</i>, and <i>RNASEH2B</i>; multigene panels available</div></li><li class="half_rhythm"><div>4 November 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 April 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 June 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>1 September 2004 (ja) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1475</span><span class="label">PMID: <a href="/pubmed/20301648" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301648</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/aic/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/alagille/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1475&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1475/?report=reader">PubReader</a></li><li><a href="/books/NBK1475/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1475" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1475" style="display:none" title="Cite this Page"><div class="bk_tt">Crow YJ. Aicardi-Goutières Syndrome. 2005 Jun 29 [Updated 2016 Nov 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1475/pdf/Bookshelf_NBK1475.pdf">PDF version of this page</a> (655K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ags.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ags.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ags.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ags.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ags.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ags.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ags.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ags.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ags.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ags.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ags.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=11277[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TREX1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=103[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ADAR</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10535[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RNASEH2A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79621[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RNASEH2B</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84153[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RNASEH2C</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=64135[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">IFIH1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=25939[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SAMHD1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1490726" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1490726" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1490726" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1490726" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24501781" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vanderver A, Tonduti D, Schiffmann R, Schmidt J, van der Knaap MS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30692772" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Recurrent Encephalopathy with Spinal Cord Involvement: An Atypical Manifestation of Aicardi-Goutières Syndrome.</a><span class="source">[Ann Indian Acad Neurol. 2019]</span><div class="brieflinkpop offscreen_noflow">Recurrent Encephalopathy with Spinal Cord Involvement: An Atypical Manifestation of Aicardi-Goutières Syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Samanta D, Ramakrishnaiah R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Indian Acad Neurol. 2019 Jan-Mar; 22(1):111-115. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25604658" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.</a><span class="source">[Am J Med Genet A. 2015]</span><div class="brieflinkpop offscreen_noflow">Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Crow YJ, Chase DS, Lowenstein Schmidt J, Szynkiewicz M, Forte GM, Gornall HL, Oojageer A, Anderson B, Pizzino A, Helman G, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2015 Feb; 167A(2):296-312. Epub 2015 Jan 16.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17846997" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical and molecular phenotype of Aicardi-Goutieres syndrome.</a><span class="source">[Am J Hum Genet. 2007]</span><div class="brieflinkpop offscreen_noflow">Clinical and molecular phenotype of Aicardi-Goutieres syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Rice G, Patrick T, Parmar R, Taylor CF, Aeby A, Aicardi J, Artuch R, Montalto SA, Bacino CA, Barroso B, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2007 Oct; 81(4):713-25. Epub 2007 Sep 4.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27643693" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.</a><span class="source">[Neuropediatrics. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Livingston JH, Crow YJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neuropediatrics. 2016 Dec; 47(6):355-360. Epub 2016 Sep 19.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301648" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301648" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d4e75f66d18aa960b37">Aicardi-Goutières Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Aicardi-Goutières Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:30:54-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE891FD3E03F4B8100000000099603CA&amp;ncbi_session=CE891FD3E040D4D1_2454SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1475%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1475&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1475/&amp;ncbi_pagename=Aicardi-Goutières Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE891FD3E040D4D1_2454SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>